CA2337495C - Melanocortin-4 receptor gene and use as a genetic marker for fat content, weight gain, and/or feed consumption of animals - Google Patents
Melanocortin-4 receptor gene and use as a genetic marker for fat content, weight gain, and/or feed consumption of animals Download PDFInfo
- Publication number
- CA2337495C CA2337495C CA002337495A CA2337495A CA2337495C CA 2337495 C CA2337495 C CA 2337495C CA 002337495 A CA002337495 A CA 002337495A CA 2337495 A CA2337495 A CA 2337495A CA 2337495 C CA2337495 C CA 2337495C
- Authority
- CA
- Canada
- Prior art keywords
- seq
- mc4r
- pig
- fat content
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003550 marker Substances 0.000 title claims abstract description 35
- 230000002068 genetic effect Effects 0.000 title claims abstract description 30
- 108010021436 Type 4 Melanocortin Receptor Proteins 0.000 title abstract description 87
- 241001465754 Metazoa Species 0.000 title abstract description 46
- 230000004584 weight gain Effects 0.000 title description 3
- 235000019786 weight gain Nutrition 0.000 title description 3
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 50
- 230000012010 growth Effects 0.000 claims abstract description 46
- 238000009395 breeding Methods 0.000 claims abstract description 11
- 230000001488 breeding effect Effects 0.000 claims abstract description 10
- 108700028369 Alleles Proteins 0.000 claims description 56
- 238000000034 method Methods 0.000 claims description 47
- 101150110867 MC4R gene Proteins 0.000 claims description 45
- 108020004414 DNA Proteins 0.000 claims description 30
- 241000282887 Suidae Species 0.000 claims description 30
- 239000012634 fragment Substances 0.000 claims description 24
- 238000004458 analytical method Methods 0.000 claims description 19
- 235000021050 feed intake Nutrition 0.000 claims description 19
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 claims description 17
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical group O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims description 16
- 239000002773 nucleotide Substances 0.000 claims description 16
- 125000003729 nucleotide group Chemical group 0.000 claims description 16
- 108091034117 Oligonucleotide Proteins 0.000 claims description 14
- 230000002503 metabolic effect Effects 0.000 claims description 13
- 230000029087 digestion Effects 0.000 claims description 12
- 101000978418 Homo sapiens Melanocortin receptor 4 Proteins 0.000 claims description 8
- 108091008146 restriction endonucleases Proteins 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 229930024421 Adenine Natural products 0.000 claims description 6
- 229960000643 adenine Drugs 0.000 claims description 6
- GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical group N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 6
- 230000003321 amplification Effects 0.000 claims description 4
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 4
- 108091027305 Heteroduplex Proteins 0.000 claims description 2
- 230000002596 correlated effect Effects 0.000 claims description 2
- 238000003935 denaturing gradient gel electrophoresis Methods 0.000 claims description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims 9
- 102100023724 Melanocortin receptor 4 Human genes 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 238000000123 temperature gradient gel electrophoresis Methods 0.000 claims 2
- 238000012360 testing method Methods 0.000 abstract description 21
- 230000008901 benefit Effects 0.000 abstract description 4
- 102000001796 Melanocortin 4 receptors Human genes 0.000 abstract 2
- 102000008316 Type 4 Melanocortin Receptor Human genes 0.000 description 80
- 238000003752 polymerase chain reaction Methods 0.000 description 39
- 241000282898 Sus scrofa Species 0.000 description 31
- 230000035772 mutation Effects 0.000 description 30
- 239000000047 product Substances 0.000 description 26
- 208000008589 Obesity Diseases 0.000 description 20
- 235000020824 obesity Nutrition 0.000 description 20
- 150000001413 amino acids Chemical class 0.000 description 19
- 241000282414 Homo sapiens Species 0.000 description 18
- 235000001014 amino acid Nutrition 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 229940024606 amino acid Drugs 0.000 description 13
- 239000000523 sample Substances 0.000 description 13
- 238000013507 mapping Methods 0.000 description 11
- 238000003556 assay Methods 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 9
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 9
- 102000004378 Melanocortin Receptors Human genes 0.000 description 9
- 108090000950 Melanocortin Receptors Proteins 0.000 description 9
- 210000000349 chromosome Anatomy 0.000 description 9
- 238000001514 detection method Methods 0.000 description 9
- 108010092277 Leptin Proteins 0.000 description 8
- 108020004705 Codon Proteins 0.000 description 7
- 108020003175 receptors Proteins 0.000 description 7
- 241000282412 Homo Species 0.000 description 6
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 6
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 6
- 102000016267 Leptin Human genes 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 229940039781 leptin Drugs 0.000 description 6
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 6
- 108010019813 leptin receptors Proteins 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000010369 molecular cloning Methods 0.000 description 6
- 230000002441 reversible effect Effects 0.000 description 6
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 5
- 102100031775 Leptin receptor Human genes 0.000 description 5
- 241000255969 Pieris brassicae Species 0.000 description 5
- 108010006785 Taq Polymerase Proteins 0.000 description 5
- 229960001230 asparagine Drugs 0.000 description 5
- 235000009582 asparagine Nutrition 0.000 description 5
- 235000003704 aspartic acid Nutrition 0.000 description 5
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000000975 dye Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000005962 receptors Human genes 0.000 description 5
- 230000011664 signaling Effects 0.000 description 5
- 238000013459 approach Methods 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000037406 food intake Effects 0.000 description 4
- 235000012631 food intake Nutrition 0.000 description 4
- 230000037433 frameshift Effects 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 102000006822 Agouti Signaling Protein Human genes 0.000 description 3
- 108010072151 Agouti Signaling Protein Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 108010000410 MSH receptor Proteins 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 101100129533 Sus scrofa MC4R gene Proteins 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 239000005557 antagonist Substances 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 231100000221 frame shift mutation induction Toxicity 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000003205 genotyping method Methods 0.000 description 3
- 102000057094 human MC4R Human genes 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 244000144972 livestock Species 0.000 description 3
- 230000004807 localization Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 235000013622 meat product Nutrition 0.000 description 3
- 239000003147 molecular marker Substances 0.000 description 3
- 230000001956 orexigenic effect Effects 0.000 description 3
- 230000003234 polygenic effect Effects 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- SNBCLPGEMZEWLU-QXFUBDJGSA-N 2-chloro-n-[[(2r,3s,5r)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CNC(=O)CCl)[C@@H](O)C1 SNBCLPGEMZEWLU-QXFUBDJGSA-N 0.000 description 2
- OPZJWMJPCNNZNT-DCAQKATOSA-N Ala-Leu-Met Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)O)N OPZJWMJPCNNZNT-DCAQKATOSA-N 0.000 description 2
- HOVPGJUNRLMIOZ-CIUDSAMLSA-N Ala-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N HOVPGJUNRLMIOZ-CIUDSAMLSA-N 0.000 description 2
- FTCGGKNCJZOPNB-WHFBIAKZSA-N Asn-Gly-Ser Chemical compound NC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FTCGGKNCJZOPNB-WHFBIAKZSA-N 0.000 description 2
- -1 BHT0433 Proteins 0.000 description 2
- 241000484025 Cuniculus Species 0.000 description 2
- 206010071602 Genetic polymorphism Diseases 0.000 description 2
- RGJKYNUINKGPJN-RWRJDSDZSA-N Glu-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(=O)O)N RGJKYNUINKGPJN-RWRJDSDZSA-N 0.000 description 2
- DURWCDDDAWVPOP-JBDRJPRFSA-N Ile-Cys-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O)N DURWCDDDAWVPOP-JBDRJPRFSA-N 0.000 description 2
- AFERFBZLVUFWRA-HTFCKZLJSA-N Ile-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)O)N AFERFBZLVUFWRA-HTFCKZLJSA-N 0.000 description 2
- GAZGFPOZOLEYAJ-YTFOTSKYSA-N Ile-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N GAZGFPOZOLEYAJ-YTFOTSKYSA-N 0.000 description 2
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 2
- LHSGPCFBGJHPCY-UHFFFAOYSA-N L-leucine-L-tyrosine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 LHSGPCFBGJHPCY-UHFFFAOYSA-N 0.000 description 2
- XQXGNBFMAXWIGI-MXAVVETBSA-N Leu-His-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)CC1=CN=CN1 XQXGNBFMAXWIGI-MXAVVETBSA-N 0.000 description 2
- IAJFFZORSWOZPQ-SRVKXCTJSA-N Leu-Leu-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O IAJFFZORSWOZPQ-SRVKXCTJSA-N 0.000 description 2
- VHNOAIFVYUQOOY-XUXIUFHCSA-N Lys-Arg-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VHNOAIFVYUQOOY-XUXIUFHCSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 2
- 108010088565 Melanocortin 5 receptor Proteins 0.000 description 2
- 108010008364 Melanocortins Proteins 0.000 description 2
- 102100034216 Melanocyte-stimulating hormone receptor Human genes 0.000 description 2
- MVQGZYIOMXAFQG-GUBZILKMSA-N Met-Ala-Arg Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCNC(N)=N MVQGZYIOMXAFQG-GUBZILKMSA-N 0.000 description 2
- USBFEVBHEQBWDD-AVGNSLFASA-N Met-Leu-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O USBFEVBHEQBWDD-AVGNSLFASA-N 0.000 description 2
- OIFHHODAXVWKJN-ULQDDVLXSA-N Met-Phe-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(O)=O)CC1=CC=CC=C1 OIFHHODAXVWKJN-ULQDDVLXSA-N 0.000 description 2
- 102000003979 Mineralocorticoid Receptors Human genes 0.000 description 2
- 108090000375 Mineralocorticoid Receptors Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
- 102100033912 Retinoic acid receptor gamma Human genes 0.000 description 2
- 102100038246 Retinol-binding protein 4 Human genes 0.000 description 2
- 101710137011 Retinol-binding protein 4 Proteins 0.000 description 2
- WUXCHQZLUHBSDJ-LKXGYXEUSA-N Ser-Thr-Asp Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(O)=O)C(O)=O WUXCHQZLUHBSDJ-LKXGYXEUSA-N 0.000 description 2
- JGUWRQWULDWNCM-FXQIFTODSA-N Ser-Val-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O JGUWRQWULDWNCM-FXQIFTODSA-N 0.000 description 2
- LMMDEZPNUTZJAY-GCJQMDKQSA-N Thr-Asp-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O LMMDEZPNUTZJAY-GCJQMDKQSA-N 0.000 description 2
- NXPDPYYCIRDUHO-ULQDDVLXSA-N Tyr-Val-His Chemical compound C([C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CC=C(O)C=C1 NXPDPYYCIRDUHO-ULQDDVLXSA-N 0.000 description 2
- FZSPNKUFROZBSG-ZKWXMUAHSA-N Val-Ala-Asp Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O FZSPNKUFROZBSG-ZKWXMUAHSA-N 0.000 description 2
- PYPZMFDMCCWNST-NAKRPEOUSA-N Val-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](C(C)C)N PYPZMFDMCCWNST-NAKRPEOUSA-N 0.000 description 2
- ZHQWPWQNVRCXAX-XQQFMLRXSA-N Val-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N ZHQWPWQNVRCXAX-XQQFMLRXSA-N 0.000 description 2
- MJOUSKQHAIARKI-JYJNAYRXSA-N Val-Phe-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=CC=C1 MJOUSKQHAIARKI-JYJNAYRXSA-N 0.000 description 2
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 description 2
- 108010081404 acein-2 Proteins 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000019439 energy homeostasis Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 2
- 210000003917 human chromosome Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 208000037493 inherited obesity Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 108010027338 isoleucylcysteine Proteins 0.000 description 2
- 108010091871 leucylmethionine Proteins 0.000 description 2
- 108010012058 leucyltyrosine Proteins 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000004213 low-fat Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000002865 melanocortin Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000006452 multicomponent reaction Methods 0.000 description 2
- 239000002751 oligonucleotide probe Substances 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 238000011056 performance test Methods 0.000 description 2
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 2
- 102000054765 polymorphisms of proteins Human genes 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 108010030587 rat melanocortin receptor type 4 Proteins 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 108091008760 retinoic acid receptors γ Proteins 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 108010000998 wheylin-2 peptide Proteins 0.000 description 2
- PNALXAODQKTNLV-JBDRJPRFSA-N Ala-Ile-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O PNALXAODQKTNLV-JBDRJPRFSA-N 0.000 description 1
- LXAARTARZJJCMB-CIQUZCHMSA-N Ala-Ile-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LXAARTARZJJCMB-CIQUZCHMSA-N 0.000 description 1
- YHKANGMVQWRMAP-DCAQKATOSA-N Ala-Leu-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YHKANGMVQWRMAP-DCAQKATOSA-N 0.000 description 1
- GMGWOTQMUKYZIE-UBHSHLNASA-N Ala-Pro-Phe Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 GMGWOTQMUKYZIE-UBHSHLNASA-N 0.000 description 1
- BOKLLPVAQDSLHC-FXQIFTODSA-N Ala-Val-Cys Chemical compound C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)O)N BOKLLPVAQDSLHC-FXQIFTODSA-N 0.000 description 1
- LYILPUNCKACNGF-NAKRPEOUSA-N Ala-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)N LYILPUNCKACNGF-NAKRPEOUSA-N 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- RIQBRKVTFBWEDY-RHYQMDGZSA-N Arg-Lys-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O RIQBRKVTFBWEDY-RHYQMDGZSA-N 0.000 description 1
- UVTGNSWSRSCPLP-UHFFFAOYSA-N Arg-Tyr Natural products NC(CCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(=O)O UVTGNSWSRSCPLP-UHFFFAOYSA-N 0.000 description 1
- NVPHRWNWTKYIST-BPNCWPANSA-N Arg-Tyr-Ala Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=C(O)C=C1 NVPHRWNWTKYIST-BPNCWPANSA-N 0.000 description 1
- ZWASIOHRQWRWAS-UGYAYLCHSA-N Asn-Asp-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZWASIOHRQWRWAS-UGYAYLCHSA-N 0.000 description 1
- GQRDIVQPSMPQME-ZPFDUUQYSA-N Asn-Ile-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O GQRDIVQPSMPQME-ZPFDUUQYSA-N 0.000 description 1
- LVHMEJJWEXBMKK-GMOBBJLQSA-N Asn-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)N)N LVHMEJJWEXBMKK-GMOBBJLQSA-N 0.000 description 1
- MYCSPQIARXTUTP-SRVKXCTJSA-N Asn-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(=O)N)N MYCSPQIARXTUTP-SRVKXCTJSA-N 0.000 description 1
- TZFQICWZWFNIKU-KKUMJFAQSA-N Asn-Leu-Tyr Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 TZFQICWZWFNIKU-KKUMJFAQSA-N 0.000 description 1
- QGABLMITFKUQDF-DCAQKATOSA-N Asn-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N QGABLMITFKUQDF-DCAQKATOSA-N 0.000 description 1
- MVXJBVVLACEGCG-PCBIJLKTSA-N Asn-Phe-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MVXJBVVLACEGCG-PCBIJLKTSA-N 0.000 description 1
- SUIJFTJDTJKSRK-IHRRRGAJSA-N Asn-Pro-Tyr Chemical compound NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 SUIJFTJDTJKSRK-IHRRRGAJSA-N 0.000 description 1
- NPZJLGMWMDNQDD-GHCJXIJMSA-N Asn-Ser-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O NPZJLGMWMDNQDD-GHCJXIJMSA-N 0.000 description 1
- ILJQISGMGXRZQQ-IHRRRGAJSA-N Asp-Arg-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ILJQISGMGXRZQQ-IHRRRGAJSA-N 0.000 description 1
- RDRMWJBLOSRRAW-BYULHYEWSA-N Asp-Asn-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O RDRMWJBLOSRRAW-BYULHYEWSA-N 0.000 description 1
- XJQRWGXKUSDEFI-ACZMJKKPSA-N Asp-Glu-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O XJQRWGXKUSDEFI-ACZMJKKPSA-N 0.000 description 1
- YFGUZQQCSDZRBN-DCAQKATOSA-N Asp-Pro-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O YFGUZQQCSDZRBN-DCAQKATOSA-N 0.000 description 1
- MGSVBZIBCCKGCY-ZLUOBGJFSA-N Asp-Ser-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MGSVBZIBCCKGCY-ZLUOBGJFSA-N 0.000 description 1
- 101100129922 Caenorhabditis elegans pig-1 gene Proteins 0.000 description 1
- 101100334009 Caenorhabditis elegans rib-2 gene Proteins 0.000 description 1
- 102100032539 Calpain-3 Human genes 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241001155433 Centrarchus macropterus Species 0.000 description 1
- 241000456591 Claea Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- GHUVBPIYQYXXEF-SRVKXCTJSA-N Cys-Cys-Tyr Chemical compound SC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 GHUVBPIYQYXXEF-SRVKXCTJSA-N 0.000 description 1
- MTNJRNQDDSWQQA-GQGQLFGLSA-N Cys-Ile-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CS)N MTNJRNQDDSWQQA-GQGQLFGLSA-N 0.000 description 1
- BSGXXYRIDXUEOM-IHRRRGAJSA-N Cys-Phe-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CS)N BSGXXYRIDXUEOM-IHRRRGAJSA-N 0.000 description 1
- YNJBLTDKTMKEET-ZLUOBGJFSA-N Cys-Ser-Ser Chemical compound SC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O YNJBLTDKTMKEET-ZLUOBGJFSA-N 0.000 description 1
- KFYPRIGJTICABD-XGEHTFHBSA-N Cys-Thr-Val Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CS)N)O KFYPRIGJTICABD-XGEHTFHBSA-N 0.000 description 1
- CLEFUAZULXANBU-MELADBBJSA-N Cys-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CS)N)C(=O)O CLEFUAZULXANBU-MELADBBJSA-N 0.000 description 1
- MQQLYEHXSBJTRK-FXQIFTODSA-N Cys-Val-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CS)N MQQLYEHXSBJTRK-FXQIFTODSA-N 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 101100520057 Drosophila melanogaster Pig1 gene Proteins 0.000 description 1
- 102100028071 Fibroblast growth factor 7 Human genes 0.000 description 1
- 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 102000030782 GTP binding Human genes 0.000 description 1
- 108091000058 GTP-Binding Proteins 0.000 description 1
- CKNUKHBRCSMKMO-XHNCKOQMSA-N Gln-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)N)C(=O)O CKNUKHBRCSMKMO-XHNCKOQMSA-N 0.000 description 1
- PNENQZWRFMUZOM-DCAQKATOSA-N Gln-Glu-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O PNENQZWRFMUZOM-DCAQKATOSA-N 0.000 description 1
- VSXBYIJUAXPAAL-WDSKDSINSA-N Gln-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O VSXBYIJUAXPAAL-WDSKDSINSA-N 0.000 description 1
- ZGHMRONFHDVXEF-AVGNSLFASA-N Gln-Ser-Phe Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ZGHMRONFHDVXEF-AVGNSLFASA-N 0.000 description 1
- BJVBMSTUUWGZKX-JYJNAYRXSA-N Gln-Tyr-His Chemical compound N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O BJVBMSTUUWGZKX-JYJNAYRXSA-N 0.000 description 1
- ZCOJVESMNGBGLF-GRLWGSQLSA-N Glu-Ile-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZCOJVESMNGBGLF-GRLWGSQLSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- BRFJMRSRMOMIMU-WHFBIAKZSA-N Gly-Ala-Asn Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O BRFJMRSRMOMIMU-WHFBIAKZSA-N 0.000 description 1
- JQFILXICXLDTRR-FBCQKBJTSA-N Gly-Thr-Gly Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)NCC(O)=O JQFILXICXLDTRR-FBCQKBJTSA-N 0.000 description 1
- BNMRSWQOHIQTFL-JSGCOSHPSA-N Gly-Val-Phe Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 BNMRSWQOHIQTFL-JSGCOSHPSA-N 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- UZZXGLOJRZKYEL-DJFWLOJKSA-N His-Asn-Ile Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UZZXGLOJRZKYEL-DJFWLOJKSA-N 0.000 description 1
- BXOLYFJYQQRQDJ-MXAVVETBSA-N His-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CN=CN1)N BXOLYFJYQQRQDJ-MXAVVETBSA-N 0.000 description 1
- KYFGGRHWLFZXPU-KKUMJFAQSA-N His-Phe-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N KYFGGRHWLFZXPU-KKUMJFAQSA-N 0.000 description 1
- GIRSNERMXCMDBO-GARJFASQSA-N His-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CC2=CN=CN2)N)C(=O)O GIRSNERMXCMDBO-GARJFASQSA-N 0.000 description 1
- 101000867715 Homo sapiens Calpain-3 Proteins 0.000 description 1
- 101001134060 Homo sapiens Melanocyte-stimulating hormone receptor Proteins 0.000 description 1
- 101001096159 Homo sapiens Pituitary-specific positive transcription factor 1 Proteins 0.000 description 1
- 101100102448 Homo sapiens VCAM1 gene Proteins 0.000 description 1
- 101000622304 Homo sapiens Vascular cell adhesion protein 1 Proteins 0.000 description 1
- MKWSZEHGHSLNPF-NAKRPEOUSA-N Ile-Ala-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O)N MKWSZEHGHSLNPF-NAKRPEOUSA-N 0.000 description 1
- ASCFJMSGKUIRDU-ZPFDUUQYSA-N Ile-Arg-Gln Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O ASCFJMSGKUIRDU-ZPFDUUQYSA-N 0.000 description 1
- UKTUOMWSJPXODT-GUDRVLHUSA-N Ile-Asn-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N UKTUOMWSJPXODT-GUDRVLHUSA-N 0.000 description 1
- NBJAAWYRLGCJOF-UGYAYLCHSA-N Ile-Asp-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N NBJAAWYRLGCJOF-UGYAYLCHSA-N 0.000 description 1
- DCQMJRSOGCYKTR-GHCJXIJMSA-N Ile-Asp-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O DCQMJRSOGCYKTR-GHCJXIJMSA-N 0.000 description 1
- PPSQSIDMOVPKPI-BJDJZHNGSA-N Ile-Cys-Leu Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)O PPSQSIDMOVPKPI-BJDJZHNGSA-N 0.000 description 1
- PFPUFNLHBXKPHY-HTFCKZLJSA-N Ile-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)O)N PFPUFNLHBXKPHY-HTFCKZLJSA-N 0.000 description 1
- AXNGDPAKKCEKGY-QPHKQPEJSA-N Ile-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N AXNGDPAKKCEKGY-QPHKQPEJSA-N 0.000 description 1
- KBAPKNDWAGVGTH-IGISWZIWSA-N Ile-Ile-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KBAPKNDWAGVGTH-IGISWZIWSA-N 0.000 description 1
- VUPHVQCDULLACF-NAKRPEOUSA-N Ile-Met-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)O)N VUPHVQCDULLACF-NAKRPEOUSA-N 0.000 description 1
- AGGIYSLVUKVOPT-HTFCKZLJSA-N Ile-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N AGGIYSLVUKVOPT-HTFCKZLJSA-N 0.000 description 1
- JJQQGCMKLOEGAV-OSUNSFLBSA-N Ile-Thr-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)O)N JJQQGCMKLOEGAV-OSUNSFLBSA-N 0.000 description 1
- DTPGSUQHUMELQB-GVARAGBVSA-N Ile-Tyr-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=C(O)C=C1 DTPGSUQHUMELQB-GVARAGBVSA-N 0.000 description 1
- ZGKVPOSSTGHJAF-HJPIBITLSA-N Ile-Tyr-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CO)C(=O)O)N ZGKVPOSSTGHJAF-HJPIBITLSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 1
- HGCNKOLVKRAVHD-UHFFFAOYSA-N L-Met-L-Phe Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-UHFFFAOYSA-N 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- BQSLGJHIAGOZCD-CIUDSAMLSA-N Leu-Ala-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O BQSLGJHIAGOZCD-CIUDSAMLSA-N 0.000 description 1
- YOZCKMXHBYKOMQ-IHRRRGAJSA-N Leu-Arg-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N YOZCKMXHBYKOMQ-IHRRRGAJSA-N 0.000 description 1
- UCOCBWDBHCUPQP-DCAQKATOSA-N Leu-Arg-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O UCOCBWDBHCUPQP-DCAQKATOSA-N 0.000 description 1
- RRSLQOLASISYTB-CIUDSAMLSA-N Leu-Cys-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(O)=O)C(O)=O RRSLQOLASISYTB-CIUDSAMLSA-N 0.000 description 1
- KUEVMUXNILMJTK-JYJNAYRXSA-N Leu-Gln-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KUEVMUXNILMJTK-JYJNAYRXSA-N 0.000 description 1
- VWHGTYCRDRBSFI-ZETCQYMHSA-N Leu-Gly-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)NCC(O)=O VWHGTYCRDRBSFI-ZETCQYMHSA-N 0.000 description 1
- QJXHMYMRGDOHRU-NHCYSSNCSA-N Leu-Ile-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O QJXHMYMRGDOHRU-NHCYSSNCSA-N 0.000 description 1
- KUIDCYNIEJBZBU-AJNGGQMLSA-N Leu-Ile-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O KUIDCYNIEJBZBU-AJNGGQMLSA-N 0.000 description 1
- QLDHBYRUNQZIJQ-DKIMLUQUSA-N Leu-Ile-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QLDHBYRUNQZIJQ-DKIMLUQUSA-N 0.000 description 1
- LIINDKYIGYTDLG-PPCPHDFISA-N Leu-Ile-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LIINDKYIGYTDLG-PPCPHDFISA-N 0.000 description 1
- NRFGTHFONZYFNY-MGHWNKPDSA-N Leu-Ile-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NRFGTHFONZYFNY-MGHWNKPDSA-N 0.000 description 1
- QNBVTHNJGCOVFA-AVGNSLFASA-N Leu-Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O QNBVTHNJGCOVFA-AVGNSLFASA-N 0.000 description 1
- RXGLHDWAZQECBI-SRVKXCTJSA-N Leu-Leu-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O RXGLHDWAZQECBI-SRVKXCTJSA-N 0.000 description 1
- SYRTUBLKWNDSDK-DKIMLUQUSA-N Leu-Phe-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SYRTUBLKWNDSDK-DKIMLUQUSA-N 0.000 description 1
- FYPWFNKQVVEELI-ULQDDVLXSA-N Leu-Phe-Val Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=CC=C1 FYPWFNKQVVEELI-ULQDDVLXSA-N 0.000 description 1
- BRTVHXHCUSXYRI-CIUDSAMLSA-N Leu-Ser-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O BRTVHXHCUSXYRI-CIUDSAMLSA-N 0.000 description 1
- LJBVRCDPWOJOEK-PPCPHDFISA-N Leu-Thr-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LJBVRCDPWOJOEK-PPCPHDFISA-N 0.000 description 1
- JGKHAFUAPZCCDU-BZSNNMDCSA-N Leu-Tyr-Leu Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C([O-])=O)CC1=CC=C(O)C=C1 JGKHAFUAPZCCDU-BZSNNMDCSA-N 0.000 description 1
- 101001090725 Leuconostoc gelidum Bacteriocin leucocin-A Proteins 0.000 description 1
- NTSPQIONFJUMJV-AVGNSLFASA-N Lys-Arg-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O NTSPQIONFJUMJV-AVGNSLFASA-N 0.000 description 1
- FACUGMGEFUEBTI-SRVKXCTJSA-N Lys-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCCN FACUGMGEFUEBTI-SRVKXCTJSA-N 0.000 description 1
- ZQCVMVCVPFYXHZ-SRVKXCTJSA-N Lys-Asn-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCCN ZQCVMVCVPFYXHZ-SRVKXCTJSA-N 0.000 description 1
- 229940126661 MC4 antagonist Drugs 0.000 description 1
- 108010018650 MEF2 Transcription Factors Proteins 0.000 description 1
- 108700005089 MHC Class I Genes Proteins 0.000 description 1
- 102000043129 MHC class I family Human genes 0.000 description 1
- 108091054437 MHC class I family Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000030612 Melanocortin 5 receptor Human genes 0.000 description 1
- 102220585316 Melanocortin receptor 5_D298N_mutation Human genes 0.000 description 1
- 108010007013 Melanocyte-Stimulating Hormones Proteins 0.000 description 1
- 101710151321 Melanostatin Proteins 0.000 description 1
- SDTSLIMYROCDNS-FXQIFTODSA-N Met-Cys-Asn Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O SDTSLIMYROCDNS-FXQIFTODSA-N 0.000 description 1
- AXHNAGAYRGCDLG-UWVGGRQHSA-N Met-Lys-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O AXHNAGAYRGCDLG-UWVGGRQHSA-N 0.000 description 1
- ZBLSZPYQQRIHQU-RCWTZXSCSA-N Met-Thr-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O ZBLSZPYQQRIHQU-RCWTZXSCSA-N 0.000 description 1
- ATBJCCFCJXCNGZ-UFYCRDLUSA-N Met-Tyr-Phe Chemical compound C([C@H](NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 ATBJCCFCJXCNGZ-UFYCRDLUSA-N 0.000 description 1
- 102100021148 Myocyte-specific enhancer factor 2A Human genes 0.000 description 1
- 108060008487 Myosin Proteins 0.000 description 1
- 102000003505 Myosin Human genes 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- XZFYRXDAULDNFX-UHFFFAOYSA-N N-L-cysteinyl-L-phenylalanine Natural products SCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UHFFFAOYSA-N 0.000 description 1
- PESQCPHRXOFIPX-UHFFFAOYSA-N N-L-methionyl-L-tyrosine Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 PESQCPHRXOFIPX-UHFFFAOYSA-N 0.000 description 1
- 102400000064 Neuropeptide Y Human genes 0.000 description 1
- 108020004485 Nonsense Codon Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- RGZYXNFHYRFNNS-MXAVVETBSA-N Phe-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N RGZYXNFHYRFNNS-MXAVVETBSA-N 0.000 description 1
- METZZBCMDXHFMK-BZSNNMDCSA-N Phe-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N METZZBCMDXHFMK-BZSNNMDCSA-N 0.000 description 1
- WLYPRKLMRIYGPP-JYJNAYRXSA-N Phe-Lys-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 WLYPRKLMRIYGPP-JYJNAYRXSA-N 0.000 description 1
- FQUUYTNBMIBOHS-IHRRRGAJSA-N Phe-Met-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N FQUUYTNBMIBOHS-IHRRRGAJSA-N 0.000 description 1
- AXIOGMQCDYVTNY-ACRUOGEOSA-N Phe-Phe-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 AXIOGMQCDYVTNY-ACRUOGEOSA-N 0.000 description 1
- MGLBSROLWAWCKN-FCLVOEFKSA-N Phe-Phe-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MGLBSROLWAWCKN-FCLVOEFKSA-N 0.000 description 1
- FGWUALWGCZJQDJ-URLPEUOOSA-N Phe-Thr-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FGWUALWGCZJQDJ-URLPEUOOSA-N 0.000 description 1
- QTDBZORPVYTRJU-KKXDTOCCSA-N Phe-Tyr-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O QTDBZORPVYTRJU-KKXDTOCCSA-N 0.000 description 1
- MMPBPRXOFJNCCN-ZEWNOJEFSA-N Phe-Tyr-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MMPBPRXOFJNCCN-ZEWNOJEFSA-N 0.000 description 1
- 102100037914 Pituitary-specific positive transcription factor 1 Human genes 0.000 description 1
- RFWXYTJSVDUBBZ-DCAQKATOSA-N Pro-Pro-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 RFWXYTJSVDUBBZ-DCAQKATOSA-N 0.000 description 1
- 108010057464 Prolactin Proteins 0.000 description 1
- 102100024819 Prolactin Human genes 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- HBZBPFLJNDXRAY-FXQIFTODSA-N Ser-Ala-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O HBZBPFLJNDXRAY-FXQIFTODSA-N 0.000 description 1
- MMAPOBOTRUVNKJ-ZLUOBGJFSA-N Ser-Asp-Ser Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CO)N)C(=O)O MMAPOBOTRUVNKJ-ZLUOBGJFSA-N 0.000 description 1
- INCNPLPRPOYTJI-JBDRJPRFSA-N Ser-Cys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CO)N INCNPLPRPOYTJI-JBDRJPRFSA-N 0.000 description 1
- RFBKULCUBJAQFT-BIIVOSGPSA-N Ser-Cys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CS)NC(=O)[C@H](CO)N)C(=O)O RFBKULCUBJAQFT-BIIVOSGPSA-N 0.000 description 1
- ZOHGLPQGEHSLPD-FXQIFTODSA-N Ser-Gln-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZOHGLPQGEHSLPD-FXQIFTODSA-N 0.000 description 1
- IOVHBRCQOGWAQH-ZKWXMUAHSA-N Ser-Gly-Ile Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O IOVHBRCQOGWAQH-ZKWXMUAHSA-N 0.000 description 1
- MOQDPPUMFSMYOM-KKUMJFAQSA-N Ser-His-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CO)N MOQDPPUMFSMYOM-KKUMJFAQSA-N 0.000 description 1
- SFTZTYBXIXLRGQ-JBDRJPRFSA-N Ser-Ile-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O SFTZTYBXIXLRGQ-JBDRJPRFSA-N 0.000 description 1
- DLPXTCTVNDTYGJ-JBDRJPRFSA-N Ser-Ile-Cys Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(O)=O DLPXTCTVNDTYGJ-JBDRJPRFSA-N 0.000 description 1
- HBTCFCHYALPXME-HTFCKZLJSA-N Ser-Ile-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HBTCFCHYALPXME-HTFCKZLJSA-N 0.000 description 1
- FUMGHWDRRFCKEP-CIUDSAMLSA-N Ser-Leu-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O FUMGHWDRRFCKEP-CIUDSAMLSA-N 0.000 description 1
- VMLONWHIORGALA-SRVKXCTJSA-N Ser-Leu-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CO VMLONWHIORGALA-SRVKXCTJSA-N 0.000 description 1
- FBLNYDYPCLFTSP-IXOXFDKPSA-N Ser-Phe-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FBLNYDYPCLFTSP-IXOXFDKPSA-N 0.000 description 1
- BSXKBOUZDAZXHE-CIUDSAMLSA-N Ser-Pro-Glu Chemical compound [H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O BSXKBOUZDAZXHE-CIUDSAMLSA-N 0.000 description 1
- OVQZAFXWIWNYKA-GUBZILKMSA-N Ser-Pro-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)N OVQZAFXWIWNYKA-GUBZILKMSA-N 0.000 description 1
- BMKNXTJLHFIAAH-CIUDSAMLSA-N Ser-Ser-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O BMKNXTJLHFIAAH-CIUDSAMLSA-N 0.000 description 1
- MFQMZDPAZRZAPV-NAKRPEOUSA-N Ser-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N MFQMZDPAZRZAPV-NAKRPEOUSA-N 0.000 description 1
- 102100038803 Somatotropin Human genes 0.000 description 1
- 101001123445 Sus scrofa Prolactin receptor Proteins 0.000 description 1
- 208000017413 Taqi polymorphism Diseases 0.000 description 1
- SLUWOCTZVGMURC-BFHQHQDPSA-N Thr-Gly-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O SLUWOCTZVGMURC-BFHQHQDPSA-N 0.000 description 1
- XOWKUMFHEZLKLT-CIQUZCHMSA-N Thr-Ile-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O XOWKUMFHEZLKLT-CIQUZCHMSA-N 0.000 description 1
- WPAKPLPGQNUXGN-OSUNSFLBSA-N Thr-Ile-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WPAKPLPGQNUXGN-OSUNSFLBSA-N 0.000 description 1
- VRUFCJZQDACGLH-UVOCVTCTSA-N Thr-Leu-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VRUFCJZQDACGLH-UVOCVTCTSA-N 0.000 description 1
- XNTVWRJTUIOGQO-RHYQMDGZSA-N Thr-Met-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O XNTVWRJTUIOGQO-RHYQMDGZSA-N 0.000 description 1
- VGYVVSQFSSKZRJ-OEAJRASXSA-N Thr-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@H](O)C)CC1=CC=CC=C1 VGYVVSQFSSKZRJ-OEAJRASXSA-N 0.000 description 1
- BKIOKSLLAAZYTC-KKHAAJSZSA-N Thr-Val-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O BKIOKSLLAAZYTC-KKHAAJSZSA-N 0.000 description 1
- PWONLXBUSVIZPH-RHYQMDGZSA-N Thr-Val-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N)O PWONLXBUSVIZPH-RHYQMDGZSA-N 0.000 description 1
- MNYNCKZAEIAONY-XGEHTFHBSA-N Thr-Val-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O MNYNCKZAEIAONY-XGEHTFHBSA-N 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- BRBCKMMXKONBAA-KWBADKCTSA-N Trp-Ala-Ala Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O)=CNC2=C1 BRBCKMMXKONBAA-KWBADKCTSA-N 0.000 description 1
- VZBWRZGNEPBRDE-HZUKXOBISA-N Trp-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N VZBWRZGNEPBRDE-HZUKXOBISA-N 0.000 description 1
- TVOGEPLDNYTAHD-CQDKDKBSSA-N Tyr-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 TVOGEPLDNYTAHD-CQDKDKBSSA-N 0.000 description 1
- QOEZFICGUZTRFX-IHRRRGAJSA-N Tyr-Cys-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(O)=O QOEZFICGUZTRFX-IHRRRGAJSA-N 0.000 description 1
- QARCDOCCDOLJSF-HJPIBITLSA-N Tyr-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N QARCDOCCDOLJSF-HJPIBITLSA-N 0.000 description 1
- JXGUUJMPCRXMSO-HJOGWXRNSA-N Tyr-Phe-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 JXGUUJMPCRXMSO-HJOGWXRNSA-N 0.000 description 1
- VBFVQTPETKJCQW-RPTUDFQQSA-N Tyr-Phe-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VBFVQTPETKJCQW-RPTUDFQQSA-N 0.000 description 1
- LIQJSDDOULTANC-QSFUFRPTSA-N Val-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)N LIQJSDDOULTANC-QSFUFRPTSA-N 0.000 description 1
- XQVRMLRMTAGSFJ-QXEWZRGKSA-N Val-Asp-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N XQVRMLRMTAGSFJ-QXEWZRGKSA-N 0.000 description 1
- DBMMKEHYWIZTPN-JYJNAYRXSA-N Val-Cys-Trp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N DBMMKEHYWIZTPN-JYJNAYRXSA-N 0.000 description 1
- PMDOQZFYGWZSTK-LSJOCFKGSA-N Val-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)C(C)C PMDOQZFYGWZSTK-LSJOCFKGSA-N 0.000 description 1
- LKUDRJSNRWVGMS-QSFUFRPTSA-N Val-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N LKUDRJSNRWVGMS-QSFUFRPTSA-N 0.000 description 1
- OVBMCNDKCWAXMZ-NAKRPEOUSA-N Val-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C(C)C)N OVBMCNDKCWAXMZ-NAKRPEOUSA-N 0.000 description 1
- APQIVBCUIUDSMB-OSUNSFLBSA-N Val-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C(C)C)N APQIVBCUIUDSMB-OSUNSFLBSA-N 0.000 description 1
- DJQIUOKSNRBTSV-CYDGBPFRSA-N Val-Ile-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](C(C)C)N DJQIUOKSNRBTSV-CYDGBPFRSA-N 0.000 description 1
- ZZGPVSZDZQRJQY-ULQDDVLXSA-N Val-Leu-Phe Chemical compound CC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O ZZGPVSZDZQRJQY-ULQDDVLXSA-N 0.000 description 1
- BCBFMJYTNKDALA-UFYCRDLUSA-N Val-Phe-Phe Chemical compound N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O BCBFMJYTNKDALA-UFYCRDLUSA-N 0.000 description 1
- GBIUHAYJGWVNLN-UHFFFAOYSA-N Val-Ser-Pro Natural products CC(C)C(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O GBIUHAYJGWVNLN-UHFFFAOYSA-N 0.000 description 1
- ZHWZDZFWBXWPDW-GUBZILKMSA-N Val-Val-Cys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(O)=O ZHWZDZFWBXWPDW-GUBZILKMSA-N 0.000 description 1
- 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 108010044940 alanylglutamine Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- 230000001539 anorectic effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 108010008355 arginyl-glutamine Proteins 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000002459 blastocyst Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 108010060199 cysteinylproline Proteins 0.000 description 1
- 230000002559 cytogenic effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 230000002922 epistatic effect Effects 0.000 description 1
- 102000015694 estrogen receptors Human genes 0.000 description 1
- 108010038795 estrogen receptors Proteins 0.000 description 1
- 238000001400 expression cloning Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 101150055782 gH gene Proteins 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 102000054767 gene variant Human genes 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 102000054766 genetic haplotypes Human genes 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 108010073628 glutamyl-valyl-phenylalanine Proteins 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 108010025306 histidylleucine Proteins 0.000 description 1
- 108010018006 histidylserine Proteins 0.000 description 1
- 230000009097 homeostatic mechanism Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 210000004754 hybrid cell Anatomy 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 230000002998 immunogenetic effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 108010078274 isoleucylvaline Proteins 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 108010030617 leucyl-phenylalanyl-valine Proteins 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000007834 ligase chain reaction Methods 0.000 description 1
- 108010009298 lysylglutamic acid Proteins 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 108010068488 methionylphenylalanine Proteins 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- RIGXBXPAOGDDIG-UHFFFAOYSA-N n-[(3-chloro-2-hydroxy-5-nitrophenyl)carbamothioyl]benzamide Chemical compound OC1=C(Cl)C=C([N+]([O-])=O)C=C1NC(=S)NC(=O)C1=CC=CC=C1 RIGXBXPAOGDDIG-UHFFFAOYSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000007372 neural signaling Effects 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- BPGXUIVWLQTVLZ-OFGSCBOVSA-N neuropeptide y(npy) Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 BPGXUIVWLQTVLZ-OFGSCBOVSA-N 0.000 description 1
- 230000037434 nonsense mutation Effects 0.000 description 1
- URPYMXQQVHTUDU-OFGSCBOVSA-N nucleopeptide y Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 URPYMXQQVHTUDU-OFGSCBOVSA-N 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 101150006864 ped gene Proteins 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 108010084572 phenylalanyl-valine Proteins 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 229940097325 prolactin Drugs 0.000 description 1
- 108700042769 prolyl-leucyl-glycine Proteins 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009892 regulation of energy homeostasis Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 102200067231 rs1805009 Human genes 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 108010048818 seryl-histidine Proteins 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 108010073969 valyllysine Proteins 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000011680 zucker rat Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/124—Animal traits, i.e. production traits, including athletic performance or the like
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Genetic markers in the porcine melanocortin-4 receptor (MC4R) gene are disclosed which are associated with fat content, growth rate, and feed consumption. Further, novel sequence data from regions of the gene are disclosed which may be used in a PCR test to screen for the presence of the marker. The genetic marker may be used to screen animals for breeding purposes which have the desired traits regarding fat content, growth rate, and feed consumption. Kits which take advantage of the PCR test are also disclosed.
Description
WO 00/06777 PCT/US9?/16862 TITLE: MELANOCORTIN-4 RECEPTOR GENE AND USE AS A GENETIC
MARKER FOR FAT CONTENT, WEIGHT GAIN, AND/OR FEED --CONSUMPTION OF ANIMALS
CROSS-REFE HTTCE TO F.LATED APPL.ICATIONy This application claims the benefit of U.S. Patent No. 5,935,784 which was filed on March 6, 1997.
GRANT RFFF FNC'F ('_ .A[ JS .
This invention was supported at least in part by grants from the United States Department of Agriculture through the Iowa AgriculUue and Home Economics Experiment Station (IaHees) and Project Number IOW03148 (Hatch Funds). The United States government may have certain rights in this invention.
FIEi .D OF THE INVENTION
The present invention relates to a method of genetically evaluating animals by assaying for the presence of at least one genetic marker which is indicative of one or more of the traits of fat content, growth rate, and feed consumption. In particular, the method analyzes for variation in the melanocortin-0 receptor (MC4R) gene which is indicative of these traits. Even more particularly, the method analyzes for a polymorphism in the MC4R
gene.
$ACKGROUND OF THE INVENTION
There is an increasing consumer demand for meat products having low fat content.
This demand is fueled by accumulating evidence in the scientific literature that a high consumption of animal fat, especially fat with a high proportion of saturated fatty acids, represents a significant health hazard, including risk for cardiovascular disease. Other health concems associated with high fat meats include their high content of cholesterol and the addition of relatively high amounts of salt which are added to improve the binding characteristics since salt aids in extracting the native water binding component myosin from the meat. Furthermore, an increasing number of consumers find meat products containing chemical additives such as phosphates, emulsifying additives, and anti-oxidants less acceptable.
Faced with consumers who seek a healthier meat product, meat producers are continually pressed to offer cheaper and healthier products.
Cheaper products, of course, come from lowering costs of production. Producers are always interested in improving the growth rate and feed conversion of their animals.
Lower production costs come from the shorter time to market and lower costs of feeding an animal. This can increase the profit margin in the livestock industry and/or result in lower prices to the consumer.
By being able to select for animals which have the aforementioned traits, producers can raise animals with these desirable characteristics. Selection for desirable traits has traditionally been done using breeding techniques.
Genetic differences exist among individual meat producing animals as well as among breeds which can be exploited by breeding techniques to achieve animals with these desirable characteristics. For example, Chinese breeds are known for reaching puberty at an early age and for their large litter size, while American breeds are known for their greater growth rates and leanness. Thus, it would be desirable to combine the best characteristics of both types of these breeds, thereby improving pork production.
Often, however, heritability for desired traits is low, for example, heritability for litter size is around l0%-15%. Standard breeding methods which select individuals based upon phenotypic variations do not take fully into account genetic variability or complex gene interactions which exist. Therefore, there is a need for an approach that deals with selection for leanness, growth rate, and feed consumption at the cellular or DNA level.
This method will provide a method for genetically evaluating animals to enable breeders to more accurately select those animals which not only phenotypically express desirable traits but those which express favorable underlying genetic criteria. This has largely been accomplished to date by marker assisted selection.
Restriction fragment length polymorphism (RFLP) analysis has been used by several groups to study pig DNA. Jung et al., Theor. ppl. Genet_, 77:271-274 (1989), discloses the use of RFLP techniques to show genetic WO 00/06777 PCT/U699.76862 variability between two pig breeds. Polymorphism was ciemonstrated for awine leukocyte antigen (SLA) Class I genes in these breeds. Hoganson et al., Abetract for AnnyaLMeetin of i Midw stern Section of theAmerican Societv of Animal Science. March 26-28, 1990, reports on the polymorphism of swine major histocompatibility complex (MfflC) genes for Chinese pigs, also demonstrated by RFLP analysis. Jung et al., Animal Gengtics. 26:79-91 (1989), reports on RFLP
analysis of SLA ClasH I genes in cxrtain boars. The authors state that the results suggest that there may be an association between ewine SY.AlMHC
i0 Claea I genes and production and performance traits. They further state that the use of SLA Class [ restriction fragments, as genetic markers, may have potential in the future for improving pig growth performance.
The ability to follow a specific favorable genetic allule involves a novel and lengthy process of the identiiScation of a DNA molecular marker for a major effect gene. The marker may be linked to a single gene with a major effect or linked to a number of genes with additive effects. DNA markers have several advantages; sc:gregation is easy to measure and is unambiguous, and DN4 markers are co-clominant, i.e., heterozygous and honiozygoua animal8 can be distinctively identified. Onoe a marker eystem i8 established selection ;zo decisions can be diatinctivel,j- identified. Once a marker syetem is established selection decisions could be made very easily, since DNA markers can be asaayed any time after a tissue or blood sample caabe collected from the individual infant aniataL
The use of een,e tic differences in receptor genes has become a valuable -is marker system for seltiction. For example, United States Patents 5,550,024 and 5,374,526 issued to Rothschild et al. disclose a polymorphism in the pig eatzogen receptor gene which is associated with larger littar size, the disclosure of which is incorporated herein by refer-a=.
United States patent number 5,935,784 discloses polymorphic markers in the pig prolactin receptor gene which are associated with larger litter size and overall reproductive efficiency.
MARKER FOR FAT CONTENT, WEIGHT GAIN, AND/OR FEED --CONSUMPTION OF ANIMALS
CROSS-REFE HTTCE TO F.LATED APPL.ICATIONy This application claims the benefit of U.S. Patent No. 5,935,784 which was filed on March 6, 1997.
GRANT RFFF FNC'F ('_ .A[ JS .
This invention was supported at least in part by grants from the United States Department of Agriculture through the Iowa AgriculUue and Home Economics Experiment Station (IaHees) and Project Number IOW03148 (Hatch Funds). The United States government may have certain rights in this invention.
FIEi .D OF THE INVENTION
The present invention relates to a method of genetically evaluating animals by assaying for the presence of at least one genetic marker which is indicative of one or more of the traits of fat content, growth rate, and feed consumption. In particular, the method analyzes for variation in the melanocortin-0 receptor (MC4R) gene which is indicative of these traits. Even more particularly, the method analyzes for a polymorphism in the MC4R
gene.
$ACKGROUND OF THE INVENTION
There is an increasing consumer demand for meat products having low fat content.
This demand is fueled by accumulating evidence in the scientific literature that a high consumption of animal fat, especially fat with a high proportion of saturated fatty acids, represents a significant health hazard, including risk for cardiovascular disease. Other health concems associated with high fat meats include their high content of cholesterol and the addition of relatively high amounts of salt which are added to improve the binding characteristics since salt aids in extracting the native water binding component myosin from the meat. Furthermore, an increasing number of consumers find meat products containing chemical additives such as phosphates, emulsifying additives, and anti-oxidants less acceptable.
Faced with consumers who seek a healthier meat product, meat producers are continually pressed to offer cheaper and healthier products.
Cheaper products, of course, come from lowering costs of production. Producers are always interested in improving the growth rate and feed conversion of their animals.
Lower production costs come from the shorter time to market and lower costs of feeding an animal. This can increase the profit margin in the livestock industry and/or result in lower prices to the consumer.
By being able to select for animals which have the aforementioned traits, producers can raise animals with these desirable characteristics. Selection for desirable traits has traditionally been done using breeding techniques.
Genetic differences exist among individual meat producing animals as well as among breeds which can be exploited by breeding techniques to achieve animals with these desirable characteristics. For example, Chinese breeds are known for reaching puberty at an early age and for their large litter size, while American breeds are known for their greater growth rates and leanness. Thus, it would be desirable to combine the best characteristics of both types of these breeds, thereby improving pork production.
Often, however, heritability for desired traits is low, for example, heritability for litter size is around l0%-15%. Standard breeding methods which select individuals based upon phenotypic variations do not take fully into account genetic variability or complex gene interactions which exist. Therefore, there is a need for an approach that deals with selection for leanness, growth rate, and feed consumption at the cellular or DNA level.
This method will provide a method for genetically evaluating animals to enable breeders to more accurately select those animals which not only phenotypically express desirable traits but those which express favorable underlying genetic criteria. This has largely been accomplished to date by marker assisted selection.
Restriction fragment length polymorphism (RFLP) analysis has been used by several groups to study pig DNA. Jung et al., Theor. ppl. Genet_, 77:271-274 (1989), discloses the use of RFLP techniques to show genetic WO 00/06777 PCT/U699.76862 variability between two pig breeds. Polymorphism was ciemonstrated for awine leukocyte antigen (SLA) Class I genes in these breeds. Hoganson et al., Abetract for AnnyaLMeetin of i Midw stern Section of theAmerican Societv of Animal Science. March 26-28, 1990, reports on the polymorphism of swine major histocompatibility complex (MfflC) genes for Chinese pigs, also demonstrated by RFLP analysis. Jung et al., Animal Gengtics. 26:79-91 (1989), reports on RFLP
analysis of SLA ClasH I genes in cxrtain boars. The authors state that the results suggest that there may be an association between ewine SY.AlMHC
i0 Claea I genes and production and performance traits. They further state that the use of SLA Class [ restriction fragments, as genetic markers, may have potential in the future for improving pig growth performance.
The ability to follow a specific favorable genetic allule involves a novel and lengthy process of the identiiScation of a DNA molecular marker for a major effect gene. The marker may be linked to a single gene with a major effect or linked to a number of genes with additive effects. DNA markers have several advantages; sc:gregation is easy to measure and is unambiguous, and DN4 markers are co-clominant, i.e., heterozygous and honiozygoua animal8 can be distinctively identified. Onoe a marker eystem i8 established selection ;zo decisions can be diatinctivel,j- identified. Once a marker syetem is established selection decisions could be made very easily, since DNA markers can be asaayed any time after a tissue or blood sample caabe collected from the individual infant aniataL
The use of een,e tic differences in receptor genes has become a valuable -is marker system for seltiction. For example, United States Patents 5,550,024 and 5,374,526 issued to Rothschild et al. disclose a polymorphism in the pig eatzogen receptor gene which is associated with larger littar size, the disclosure of which is incorporated herein by refer-a=.
United States patent number 5,935,784 discloses polymorphic markers in the pig prolactin receptor gene which are associated with larger litter size and overall reproductive efficiency.
:C1'. Vt)N : L:PA k91iE1'Ctl(:N 06 ~ 13- :f- 0:CA 02337495 2001-01-26 ;15 288 1338-= +40 89 222:3:394465 : It 9 WO-A-97/47316 discloses that mutations in the MC4R protein exist in extremely obese human patients and that a predisposition to body weight disorders can be ascertained by testing for mutations in i.he MC4R gene.
However, Gotoda et ill., Diabetologia 40 (1997) 976 disclose a lack of correlation between tl particular point mutation in the MC4R gene (VaII03Ile) and obesity in white human males. There was therefore no indication in the art of a correlation bE-tween the MC4R gene and a means for selecting animals with improved metabolic traits.
It can be seen irom the foregoing that a need exists for a method for t0 selecting animals with the improved metabolic traits regarding fat content, growth rate, and feed consumption.
AMENDED SHEET
WO 00/06777 PCT/US99/16862 "
SUMMARY OF THE INVENTION
An object of the present invention is to provide a genetic marker based on or within -the MC4R gene which is indicative of fat content, growth rate, and/or feed consumption.
Another object of the invention is to provide an assay for determining the presence of this genetic marker.
A further object of the invention is to provide a method of evaluating animals that increases accuracy of selection and breeding methods for the desired traits.
Yet another object of the invention is to provide a PCR amplification test which will greatly expedite the determination of presence of the marker.
An additional object of the invention is to provide a kit for evaluating a sample of animal DNA for the identified genetic marker.
These and other objects, features, and advantages will become apparent after review of the following description and claims of the invention which follow.
This invention relates to the discovery of a polymorphism within the melanocortin-4 receptor (MC4R) gene which is associated with fat content, growth rate, and feed conversion traits in animals. According to the invention, the association of the MC4R
polymorphism with the trait(s) enables genetic markers to be identified for specific breeds or genetic lines. The TaqI restriction pattern which identifies the polymorphism is used to assay for the presence or absence of markers associated with the desirable metabolic traits.
The breed-dependent marker genotype (i.e., a marker in some breeds and a nonmarker in others) consists of a polymorphism within MC4R, a guanine to adenine transition at position 678 of the PCR product (a missense mutation of aspartic acid codon (GAU) into asparagine codon (AAU) at position 298 amino acid of the MC4R protein). The invention includes assays for detection of the marker as well as the sequence characterization of the polymorphism and includes novel sequences in the MC4R gene which may be used to design amplification primers for such an assay. Additionally, the invention includes a method for using the assay in breeding programs for animal selection and a kit for performing the assay.
Definitions As used herein, "low fat content" or "leanness" means a biologically significant decrease in body fat relative to the mean of a given population.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is the sequence listing for MC4R in pigs (SEQ ID NO:1). "X"
represents the site of the polymorphism.
Figure 2 represents a comparison of the DNA sequence between the human (SEQ
ID NO:2) and the porcine (SEQ ID NO:3) MC4R gene.
Figure 3 represents a comparison of the amino acid sequence between the human (SEQ ID NO:4) and the porcine (SEQ ID NO:5) MC4R gene.
Figures 4a, 4b, and 4c are linkage reports for MC4R from CRI-MAP.
Figure 5 depicts partial nucleotide and amino acid sequences (SEQ ID NO: 12) of the porcine MC4R gene. The amino acid translation shows an amino acid substitution at codon 298.
Figure 6 is an electrophoresis gel of TaqI digestion of the PCR product.
Molecular marker (M) and MC4R genotypes are indicated at the top of each lane.
Figure 7 depicts multiple-alignments of the putative seventh transmembrane domain of porcine MC4R with other MCRs and GPCRs. The "*" represents the predicted sequence positions for porcine MC4R. The other amino acid sequences were obtained from the GenBank database (accession numbers P32245, P70596, P41983, P56451, P34974, P41968, P33033, Q01718, Q01726, Q28031, AF011466, P21554, P18089, P30680, P47211). The missense variant in porcine MC4R substituted amino acid N
for D
in the position marked with an arrow. The Asp (D) residue is highly conserved among MCRs, and the Asn (N) residue is well conserved in most other GPCRs.
DETAILED DESCRIPTION OF THE PREFEIZRFD EMBODI--ENT
Obesity is a disease affecting energy balance. The control of energy metabolism is simple: store excessive energy as fat and manage the energy to avoid superfluous energy storage, i.e., obesity. Although several genes and signaling systems have been implicated in obesity, there has been little known about the interconnection of energy homeostatic mechanism and genetic polymorphism. The melanocortin-4 receptor (MC4R) has been 3 0 shown to be an important mediator of long term weight homeostasis. MC4R
antagonists can increase food intake and body weight during chronic administration.
Skuladottir, G.V., et al., "Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist", British J. of Pharm., 126(l):27-34 (1999).
Lu et al. (1994) suggested that the melanocortin receptors are involved in controlling food intake and energy balance through studying its antagonism to the agouti obesity syndrome. Huszar et al. (1997) found that inactivation of the melanocortin-4 receptor gene (MC4R) resulted in a maturity onset obesity syndrome in mice and demonstrated a major role of MC4R protein in the regulation of energy balance related to the agouti obesity syndrome. In addition, the MC4R protein mediates the effects of leptin, one of the important signaling molecules in energy homeostasis (Seeley et al.
1997).
According to the present invention, a variant or polymorphism in the MC4R gene has been located, and this genetic variability is associated with phenotypic differences in the metabolic traits of fat content, growth rate, and/or feed consumption.
In one embodiment of the invention, an assay is provided for detection of presence of a desirable genotype. The assay involves amplifying the genomic DNA
purified from blood, tissue, semen, or other convenient source of genetic material by the use of primers and standard techniques, such as the polymerase chain reaction (PCR), then digesting the DNA with a restriction enzyme (e.g., Taq 1) so as to yield gene fragments of varying lengths, and separating at least some of the fragments from others (e.g., using electrophoresis).
The fragments may also be detected by hybridizing with a nucleotide probe (e.g., radio-labeled cDNA probes) that contains all or at least a portion of the MC4R
gene cDNA
sequence to the separated fragments and comparing the results of the hybridization with assay results for a gene sequence known to have the marker or a sequence known to not have the marker. Selection and use of probes for detection of MC4R sequences based on the known and disclosed MC4R sequences is generally known to those skilled in the art.
The probe may be any sequence which will hybridize to the separated digestion products and allow for detection.
Another embodiment of the invention provides a kit for assaying the presence in a MC4R gene sequence of a genetic marker. The marker being indicative of inheritable traits of fat content, growth rate, and/or feed consumption. The kit in a preferred embodiment also includes novel PCR primers comprising 4-30 contiguous bases on either side of the polymorphism to provide an amplification system allowing for detection of the Taq I
polymorphism by PCR and Taq I digestion of PCR products. The preferred primers are SEQ ID NO:8 and SEQ ID NO:9.
A further embodiment comprises a breeding method whereby an assay of the above type is conducted on a plurality of gene sequences from different animals or animal embryos to be selected from and based on the results, certain animals are either selected or dropped out of the breeding program.
According to the invention, the polymorphism in the MC4R gene, identifiable by the Taq I restriction pattern, is disclosed. As is known in the art, restriction patterns are not exact determinants of the size of fragments and are only approximate. The polymorphism is identifiable by three bands from a Taq I digestion of the PCR product, 466, 225, and 76 base pairs (bp) for one homozygous genotype (allele 1); two bands, 542 and 225 bp for another homozygous genotype (allele 2); and four bands for the heterozygous genotype (542, 466, 225, and 76 bp). The marker for leanness and lower feed intake is identifiable by the 466/225/76 bands, except for the Chinese pigs, where the Chinese pigs' marker for leanness is the 542/225 bands. The marker for faster rate of gain is identifiable by the 542/225 bands.
In addition, the polymorphism associated with the pattem has been identified at the nucleotide level. The polymorphic Taq I site was sequenced along with the general surrounding area. See SEQ ID NO: 1. The sequences surrounding the polymorphism have facilitated the development of a PCR test in which a primer of about 4-30 contiguous bases taken from the sequence immediately adjacent to the polymorphism is used in connection with a polymerase chain reaction to greatly amplify the region before treatment with the Taq I restriction enzyme. The primers need not be the exact complement;
substantially equivalent sequences are acceptable.
From sequence data, it was observed that in allele 2 the guanine is substituted with an adenine at position 678 of the PCR product or at position 298 amino acid of the MC4R
protein changing the aspartic acid codon (GAU) into an asparagine codon (AAU).
The PCR test for the polymorphism used a forward primer of 5'-TGG CAA TAG CCA AGA
3 0 ACA AG-3' (SEQ. ID NO: 6) and a reverse primer of 5'-CAG GGG ATA GCA ACA
GAT GA-3' (SEQ. ID NO: 7). Pig specific primers used were a forward primer of 5'-TTA
AGT GGA GGA AGA AGG-3' (SEQ. ID NO: 8) and a reverse primer of 5'-CAT TAT
GAC AGT TAA GCG G-3' (SEQ ID NO:9). The resulting amplified product of about bp, when digested with Taq I, results in allelic fragments of 466, 225, and 76 bp (allele 1) or 542 and 225 bp (allele 2).
The marker may be identified by any method known to one of ordinary skill in the art which identifies the presence or absence of the marker, including for example, single-strand conformation polymorphism analysis (SSCP), RFLP analysis, heteroduplex analysis, denaturing gradient gel electrophoresis, and temperature gradient electrophoresis, ligase chain reaction or even direct sequencing of the MC4R gene and examination for the Taq I RFLP recognition pattern.
One or more additional restriction enzymes and/or probes and/or primers can be used. Additional enzymes, constructed probes, and primers can be determined by routine experimentation by those of ordinary skill in the art.
Other possible techniques include non-gel systems such as TaqManTM (Perkin Elmer). In this system, oligonucleotide PCR primers are designed that flank the mutation in question and allow PCR amplification of the region. A third oligonucleotide probe is then designed to hybridize to the region containing the base subject to change between different alleles of the gene. This probe is labeled with fluorescent dyes at both the 5' and 3' ends. These dyes are chosen such that while in this proximity to each other the fluorescence of one of them is quenched by the other and cannot be detected.
Extension by Taq DNA polymerase from the PCR primer positioned 5' on the template relative to the probe leads to the cleavage of the dye attached to the 5' end of the annealed probe through the 5' nuclease activity of the Taq DNA polymerase. This removes the quenching effect allowing detection of the fluorescence from the dye at the 3' end of the probe. The discrimination between different DNA sequences arises through the fact that if the hybridization of the probe to the template molecule is not complete, i.e., there is a mismatch of some form, the cleavage of the dye does not take place. Thus, only if the nucleotide sequence of the oligonucleotide probe is completely complementary to the template molecule to which it is bound will quenching be removed. A reaction mix can contain two different probe sequences each designed against different alleles that might be present, thus, allowing the detection of both alleles in on reaction.
However, Gotoda et ill., Diabetologia 40 (1997) 976 disclose a lack of correlation between tl particular point mutation in the MC4R gene (VaII03Ile) and obesity in white human males. There was therefore no indication in the art of a correlation bE-tween the MC4R gene and a means for selecting animals with improved metabolic traits.
It can be seen irom the foregoing that a need exists for a method for t0 selecting animals with the improved metabolic traits regarding fat content, growth rate, and feed consumption.
AMENDED SHEET
WO 00/06777 PCT/US99/16862 "
SUMMARY OF THE INVENTION
An object of the present invention is to provide a genetic marker based on or within -the MC4R gene which is indicative of fat content, growth rate, and/or feed consumption.
Another object of the invention is to provide an assay for determining the presence of this genetic marker.
A further object of the invention is to provide a method of evaluating animals that increases accuracy of selection and breeding methods for the desired traits.
Yet another object of the invention is to provide a PCR amplification test which will greatly expedite the determination of presence of the marker.
An additional object of the invention is to provide a kit for evaluating a sample of animal DNA for the identified genetic marker.
These and other objects, features, and advantages will become apparent after review of the following description and claims of the invention which follow.
This invention relates to the discovery of a polymorphism within the melanocortin-4 receptor (MC4R) gene which is associated with fat content, growth rate, and feed conversion traits in animals. According to the invention, the association of the MC4R
polymorphism with the trait(s) enables genetic markers to be identified for specific breeds or genetic lines. The TaqI restriction pattern which identifies the polymorphism is used to assay for the presence or absence of markers associated with the desirable metabolic traits.
The breed-dependent marker genotype (i.e., a marker in some breeds and a nonmarker in others) consists of a polymorphism within MC4R, a guanine to adenine transition at position 678 of the PCR product (a missense mutation of aspartic acid codon (GAU) into asparagine codon (AAU) at position 298 amino acid of the MC4R protein). The invention includes assays for detection of the marker as well as the sequence characterization of the polymorphism and includes novel sequences in the MC4R gene which may be used to design amplification primers for such an assay. Additionally, the invention includes a method for using the assay in breeding programs for animal selection and a kit for performing the assay.
Definitions As used herein, "low fat content" or "leanness" means a biologically significant decrease in body fat relative to the mean of a given population.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is the sequence listing for MC4R in pigs (SEQ ID NO:1). "X"
represents the site of the polymorphism.
Figure 2 represents a comparison of the DNA sequence between the human (SEQ
ID NO:2) and the porcine (SEQ ID NO:3) MC4R gene.
Figure 3 represents a comparison of the amino acid sequence between the human (SEQ ID NO:4) and the porcine (SEQ ID NO:5) MC4R gene.
Figures 4a, 4b, and 4c are linkage reports for MC4R from CRI-MAP.
Figure 5 depicts partial nucleotide and amino acid sequences (SEQ ID NO: 12) of the porcine MC4R gene. The amino acid translation shows an amino acid substitution at codon 298.
Figure 6 is an electrophoresis gel of TaqI digestion of the PCR product.
Molecular marker (M) and MC4R genotypes are indicated at the top of each lane.
Figure 7 depicts multiple-alignments of the putative seventh transmembrane domain of porcine MC4R with other MCRs and GPCRs. The "*" represents the predicted sequence positions for porcine MC4R. The other amino acid sequences were obtained from the GenBank database (accession numbers P32245, P70596, P41983, P56451, P34974, P41968, P33033, Q01718, Q01726, Q28031, AF011466, P21554, P18089, P30680, P47211). The missense variant in porcine MC4R substituted amino acid N
for D
in the position marked with an arrow. The Asp (D) residue is highly conserved among MCRs, and the Asn (N) residue is well conserved in most other GPCRs.
DETAILED DESCRIPTION OF THE PREFEIZRFD EMBODI--ENT
Obesity is a disease affecting energy balance. The control of energy metabolism is simple: store excessive energy as fat and manage the energy to avoid superfluous energy storage, i.e., obesity. Although several genes and signaling systems have been implicated in obesity, there has been little known about the interconnection of energy homeostatic mechanism and genetic polymorphism. The melanocortin-4 receptor (MC4R) has been 3 0 shown to be an important mediator of long term weight homeostasis. MC4R
antagonists can increase food intake and body weight during chronic administration.
Skuladottir, G.V., et al., "Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist", British J. of Pharm., 126(l):27-34 (1999).
Lu et al. (1994) suggested that the melanocortin receptors are involved in controlling food intake and energy balance through studying its antagonism to the agouti obesity syndrome. Huszar et al. (1997) found that inactivation of the melanocortin-4 receptor gene (MC4R) resulted in a maturity onset obesity syndrome in mice and demonstrated a major role of MC4R protein in the regulation of energy balance related to the agouti obesity syndrome. In addition, the MC4R protein mediates the effects of leptin, one of the important signaling molecules in energy homeostasis (Seeley et al.
1997).
According to the present invention, a variant or polymorphism in the MC4R gene has been located, and this genetic variability is associated with phenotypic differences in the metabolic traits of fat content, growth rate, and/or feed consumption.
In one embodiment of the invention, an assay is provided for detection of presence of a desirable genotype. The assay involves amplifying the genomic DNA
purified from blood, tissue, semen, or other convenient source of genetic material by the use of primers and standard techniques, such as the polymerase chain reaction (PCR), then digesting the DNA with a restriction enzyme (e.g., Taq 1) so as to yield gene fragments of varying lengths, and separating at least some of the fragments from others (e.g., using electrophoresis).
The fragments may also be detected by hybridizing with a nucleotide probe (e.g., radio-labeled cDNA probes) that contains all or at least a portion of the MC4R
gene cDNA
sequence to the separated fragments and comparing the results of the hybridization with assay results for a gene sequence known to have the marker or a sequence known to not have the marker. Selection and use of probes for detection of MC4R sequences based on the known and disclosed MC4R sequences is generally known to those skilled in the art.
The probe may be any sequence which will hybridize to the separated digestion products and allow for detection.
Another embodiment of the invention provides a kit for assaying the presence in a MC4R gene sequence of a genetic marker. The marker being indicative of inheritable traits of fat content, growth rate, and/or feed consumption. The kit in a preferred embodiment also includes novel PCR primers comprising 4-30 contiguous bases on either side of the polymorphism to provide an amplification system allowing for detection of the Taq I
polymorphism by PCR and Taq I digestion of PCR products. The preferred primers are SEQ ID NO:8 and SEQ ID NO:9.
A further embodiment comprises a breeding method whereby an assay of the above type is conducted on a plurality of gene sequences from different animals or animal embryos to be selected from and based on the results, certain animals are either selected or dropped out of the breeding program.
According to the invention, the polymorphism in the MC4R gene, identifiable by the Taq I restriction pattern, is disclosed. As is known in the art, restriction patterns are not exact determinants of the size of fragments and are only approximate. The polymorphism is identifiable by three bands from a Taq I digestion of the PCR product, 466, 225, and 76 base pairs (bp) for one homozygous genotype (allele 1); two bands, 542 and 225 bp for another homozygous genotype (allele 2); and four bands for the heterozygous genotype (542, 466, 225, and 76 bp). The marker for leanness and lower feed intake is identifiable by the 466/225/76 bands, except for the Chinese pigs, where the Chinese pigs' marker for leanness is the 542/225 bands. The marker for faster rate of gain is identifiable by the 542/225 bands.
In addition, the polymorphism associated with the pattem has been identified at the nucleotide level. The polymorphic Taq I site was sequenced along with the general surrounding area. See SEQ ID NO: 1. The sequences surrounding the polymorphism have facilitated the development of a PCR test in which a primer of about 4-30 contiguous bases taken from the sequence immediately adjacent to the polymorphism is used in connection with a polymerase chain reaction to greatly amplify the region before treatment with the Taq I restriction enzyme. The primers need not be the exact complement;
substantially equivalent sequences are acceptable.
From sequence data, it was observed that in allele 2 the guanine is substituted with an adenine at position 678 of the PCR product or at position 298 amino acid of the MC4R
protein changing the aspartic acid codon (GAU) into an asparagine codon (AAU).
The PCR test for the polymorphism used a forward primer of 5'-TGG CAA TAG CCA AGA
3 0 ACA AG-3' (SEQ. ID NO: 6) and a reverse primer of 5'-CAG GGG ATA GCA ACA
GAT GA-3' (SEQ. ID NO: 7). Pig specific primers used were a forward primer of 5'-TTA
AGT GGA GGA AGA AGG-3' (SEQ. ID NO: 8) and a reverse primer of 5'-CAT TAT
GAC AGT TAA GCG G-3' (SEQ ID NO:9). The resulting amplified product of about bp, when digested with Taq I, results in allelic fragments of 466, 225, and 76 bp (allele 1) or 542 and 225 bp (allele 2).
The marker may be identified by any method known to one of ordinary skill in the art which identifies the presence or absence of the marker, including for example, single-strand conformation polymorphism analysis (SSCP), RFLP analysis, heteroduplex analysis, denaturing gradient gel electrophoresis, and temperature gradient electrophoresis, ligase chain reaction or even direct sequencing of the MC4R gene and examination for the Taq I RFLP recognition pattern.
One or more additional restriction enzymes and/or probes and/or primers can be used. Additional enzymes, constructed probes, and primers can be determined by routine experimentation by those of ordinary skill in the art.
Other possible techniques include non-gel systems such as TaqManTM (Perkin Elmer). In this system, oligonucleotide PCR primers are designed that flank the mutation in question and allow PCR amplification of the region. A third oligonucleotide probe is then designed to hybridize to the region containing the base subject to change between different alleles of the gene. This probe is labeled with fluorescent dyes at both the 5' and 3' ends. These dyes are chosen such that while in this proximity to each other the fluorescence of one of them is quenched by the other and cannot be detected.
Extension by Taq DNA polymerase from the PCR primer positioned 5' on the template relative to the probe leads to the cleavage of the dye attached to the 5' end of the annealed probe through the 5' nuclease activity of the Taq DNA polymerase. This removes the quenching effect allowing detection of the fluorescence from the dye at the 3' end of the probe. The discrimination between different DNA sequences arises through the fact that if the hybridization of the probe to the template molecule is not complete, i.e., there is a mismatch of some form, the cleavage of the dye does not take place. Thus, only if the nucleotide sequence of the oligonucleotide probe is completely complementary to the template molecule to which it is bound will quenching be removed. A reaction mix can contain two different probe sequences each designed against different alleles that might be present, thus, allowing the detection of both alleles in on reaction.
Though the use of RFLPs is one method of detecting the polymorphism, other methods known to one of ordinary skill in the art may be used. Such methods include ongs that analyze the polymorphic gene product and detect polymorphisms by detecting the resulting differences in the gene product.
Though the preferred method of separating restriction fragments is gel electrophoresis, other alternative methods known to one skilled in the art may be used to separate and determine the size of the restriction fragments.
It is possible to indirectly select for the polymorphism with alternative DNA
markers. It is possible to establish a linkage between specific alleles of alternative DNA
markers and alleles of DNA markers known to be associated with the MC4R gene which have previously been shown to be associated with a particular trait. Examples of markers on the published PiGMaP chromosome map which are linked to the MC4R gene include S0331, BHT0433, and S0313.
The reagents suitable for applying the methods of the present invention may be packaged into convenient kits. The kits provide the necessary materials, packaged into suitable containers. At a minimum, the kit contains a reagent that identifies the polymorphism in the MC4R gene that is associated with the traits of interest, fat content, growth rate, and feed consumption. Preferably, the reagent that identifies the polymorphism is a PCR set (a set of primers, DNA polymerase, and four nucleoside triphosphates) that hybridize with the MC4R gene or a fragment thereof.
Preferably, the PCR set and restriction enzyme that cleaves the MC4R gene in at least one place are included in the kit. Preferably, the kit further comprises additional means, such as reagents, for detecting or measuring the detectable entity or providing a control. Other reagents used for hybridization, prehybridization, DNA extraction, visualization, and similar purposes may also be included, if desired.
The genetic markers, methods, and kits of the invention are useful in a breeding program to improve fat content, growth rate, and feed consumption characteristics in a breed, line, or population of animals. Continuous selection and breeding of animals that are at least heterozygous and preferably homozygous for the desired polymorphism associated with the particular trait would lead to a breed, line, or population having those desired traits. Thus, the marker is a selection tool.
Though the preferred method of separating restriction fragments is gel electrophoresis, other alternative methods known to one skilled in the art may be used to separate and determine the size of the restriction fragments.
It is possible to indirectly select for the polymorphism with alternative DNA
markers. It is possible to establish a linkage between specific alleles of alternative DNA
markers and alleles of DNA markers known to be associated with the MC4R gene which have previously been shown to be associated with a particular trait. Examples of markers on the published PiGMaP chromosome map which are linked to the MC4R gene include S0331, BHT0433, and S0313.
The reagents suitable for applying the methods of the present invention may be packaged into convenient kits. The kits provide the necessary materials, packaged into suitable containers. At a minimum, the kit contains a reagent that identifies the polymorphism in the MC4R gene that is associated with the traits of interest, fat content, growth rate, and feed consumption. Preferably, the reagent that identifies the polymorphism is a PCR set (a set of primers, DNA polymerase, and four nucleoside triphosphates) that hybridize with the MC4R gene or a fragment thereof.
Preferably, the PCR set and restriction enzyme that cleaves the MC4R gene in at least one place are included in the kit. Preferably, the kit further comprises additional means, such as reagents, for detecting or measuring the detectable entity or providing a control. Other reagents used for hybridization, prehybridization, DNA extraction, visualization, and similar purposes may also be included, if desired.
The genetic markers, methods, and kits of the invention are useful in a breeding program to improve fat content, growth rate, and feed consumption characteristics in a breed, line, or population of animals. Continuous selection and breeding of animals that are at least heterozygous and preferably homozygous for the desired polymorphism associated with the particular trait would lead to a breed, line, or population having those desired traits. Thus, the marker is a selection tool.
The following examples are offered to illustrate, but not limit the invention.
Melanocortin 4 Receptor PCR-RFLP Test - TaqI polymorphism and Genetic Linkage Mapping of MC4R Gene Primers:
Primers were designed from homologous regions of human and rat MC4R
sequences (Genbank Accession No. s77415 and u67863, respectively). These primers were used to amplify a 750-bp sequence of the porcine MC4R gene.
MC4R1: 5' TGG CAA TAG CCA AGA ACA AG 3' (SEQ ID NO:6) MC4R4: 5' CAG GGG ATA GCA ACA GAT GA 3' (SEQ ID NO:7) PCR Conditions:
Mix 1: l OX Promega Buffer 1.0 L
mM MgCl2 0.6 L
dNTPs mix (2.5mM each) 0.5 L
25 pmoV L MC4R1 0.1 L
25 pmol/ L MC4R4 0.1 L
dd sterile H20 7.5 L
Taq Polymerase (5 U/ L) 0.07 L
Genomic DNA (12.5 ng/ L) 1.0 L
Ten L of Mix 1 and DNA were combined in reaction tube, then overlaid with mineral oil. The following PCR program was run: 94 C for 2 min.; 35 cycles of 94 C for 20 30 sec.; 58 C 1 min., and 72 C 1 min. 30 sec.; followed by a final extension at 72 C for 15 min.
Five l of the PCR reaction product was checked on a standard 1% agarose gel to confirm amplification success and clean negative control. Product size is approximately , 750 base pairs. Digestion was performed by the following procedure.
TaqI Digestion Reaction 10 IaL reaction PCR product 5.0 L
l OX TaqI NE Buffer 1.0 L
BSA (10mg/ml) 0.1 L
Taql enzyme (20 U/ L) 0.5 L
dd sterile H20 3.4 L
A cocktail of the buffer, enzyme, BSA, and water was made. Five L was added to each reaction tube containing the DNA. The mixture was then incubated at 65 C
for at least 4 hours to overnight. Loading dye was mixed with the digestion reaction and the total volume was loaded on a 3% agarose gel. The major bands for allele I are about 466, 225, and 76 bp. The allele 2 genotype bands are 542 and 225 bp. The heterozygote genotype has both allele I and allele 2.
R t The amplified PCR product is about 750 bp. The sequence of the PCR product confirmed that the PCR product is MC4R gene with 97.6%, and 92.2% identities at the amino acid and DNA level, respectively, to corresponding human sequences. (see Figs. 2 and 3).
The Taql digestion of the PCR product produced allelic fragments of 466, 225, and 76 bp (allele 1), or 542 and 225 bp (allele 2). The heterozygote genotype has both types of alleles. Mendelian inheritance was observed in three three-generation international reference families, which were used to map this gene by linkage analysis.
The polymorphism between allele 1 and allele 2 resulting from a G-* A
transition at position 678 of the PCR product revealed a missense mutation of Aspartic acid codon (GAU) into Asparagine codon (AAU) at position 298 amino acid of MC4R protein.
(See Figure 1, SEQ ID NO:1).
Allele frequencies were determined by genotyping of DNA samples from a small number of animals from different breeds (Table 1). Allele I was observed with a frequency of 1 in Meishan, but was not observed or observed at very low frequency in Hampshire and Yorkshire. The frequencies of allele 1 in Landrace and Chester White were 0.5, respectively.
Figures 2 and 3 illustrate the differences between the DNA and amino acid sequences of the human and porcine MC4R gene (SEQ ID NOS:2-5).
The Frequencv of Allele 1 in Different Pig Breeds Breed # Animals Freq. Allele 1 Meishan 8 1 Large White 8 0.56 Yorkshire 6 0.08 Hampshire 5 0 Landrace 4 0.5 Chester White 4 0.5 Minzu 2 1 Wild Boar 2 1 Linkage Analyses Two-point and multi-point linkage analyses were performed on the genotypes of international reference families. See Figs. 4a-4c. The data were analyzed by using the CRI-MAP program. MC4R was significantly linked to several markers on porcine chromosome (SSC) 1. The most closely linked markers (recombination fraction and LOD
score in parentheses) are S0331 (0.02, 21.97), BHT0433 (0.02, 21.32), and S0313 (0.00, 17.76) by two-point linkage analysis. A multi-point linkage analysis produced the best map order of markers and MC4R (with distance in Kosambi cM): KGF-5.8-CAPN3-2.5-MEF2A-6.1-MC4R-5.6-S0313.
Somatic cell hybrid panel of pig and rodent was used to assign MC4R to a cytogenetic region. PCR products from pig specific primers were amplified in clones 7, $_ 16, 18, and 19. MC4R was localized to SSCIq 22-27.
MC4R Receptor PCR-RFLP Test using Pig Specific Primers and Genetic Linkage Mapping of the Porcine MC4R Gene PigSnecific Primer Sequences Forward primer: 5'-TTA AGT GGA GGA AGA AGG-3' (SEQ ID NO:8) Reverse primer: 5'-CAT TAT GAC AGT TAA GCG G-3' (SEQ ID NO:9) Method of Detection The PCR reaction was performed using Porcine genomic DNA 12.5 ng 1 x PCR buffer MgCIZ 1.5 mM
dNTP 0.125 mM
Forward primer 0.3 M
Reverse primer 0.3 M
Taq DNA polymerase (Promega) 0.35 U
in a 10 L final volume. The PCR profile included 2 min. at 94 C; 35 cycles of 30 sec. at 94 C, 1 min. at 56 C, 1 min. 30 sec. at 72 C; and 15 min. at 72 C in a Robocycler (Statagene, La Jolla, CA). A 5.0 L aliquot of the PCR products was digested in a total volume of 10 L with 10 U of Taql incubated overnight at 65 C. The digestion products were electrophoresed on a 3% agarose gel.
Description of Pol,ymornhism The TaqI digestion of the PCR product produced fragments of 466, 225, and 76 bR -in allele I and 542 and 225 bp in allele 2. The heterozygous genotype has fragments of both allele 1 and allele 2.
Pattern of Inheritance Autosomal segregation of Mendelian inheritance was observed in three three-generation European PiGMaP families (Archibald et al., 1995).
Allele Frequencies Allele frequencies were determined by genotyping the grandparental animals of the European PiGMaP families and unrelated animals from ISU reference families.
Allele 1 was observed with the following frequencies.
The Frequency of Allele I in Different Pig Breeds Breed # Animals Freq. Allele 1 Meishan 8 1 Large White 8 0.56 Yorkshire 10 0.15 Hampshire 12 0 Landrace 8 0.56 Chester White 8 0.56 Minzu 2 1 Wild Boar 2 1 Chromosomal Location Two-point and multi-point linkage analysis were performed on the genotypes of three PiGMaP families using the CRI-MAP program (Green et al. 1990). MC4R was significantly linked to several markers on porcine chromosome 1(SSC 1). The most closely linked markers (recombination fraction and LOD score in parentheses) are S0331 -(0.02, 21.97), BHT0433 (0.02, 21.32), and S0313 (0.00, 17.76) according to two-point linkage analysis. The best map order of MC4R with respect to other linked markers produced by multi-point linkage analysis is as follows (with distance in Kosambi cM):
KGF-5.8-CAPN3-2.5 -MEF2A-6.1-MC4R-5.6-SO313.
Comments The Melanocortin-4 Receptor is a G protein-coupled, seven-transmembrane receptor expressed in the brain. Huszar et al. (1997) found that inactivation of MC4R gene resulted in a maturity onset obesity syndrome in mice and demonstrated a major role of MC4R protein in the regulation of energy balance. The MC4R gene has been mapped to human chromosome 18q21.3 (Gantz et al., 1993). The localization of MC4R gene to SSC
1 is consistent with previous chromosome painting data indicating synteny between this chromosome and HSA 18 and 15 (Goureau et al., 1996). However, the gene order of several genes previously mapped from HSA 18 and 15 to SSC 1, including CAPN3, KGF, and MEF2A, is not conserved with MC4R. Therefore, mapping of MC4R to SSC 1 may identify an evolutionary breakpoint between HSA 18 and 15 in relation to SSC
1.
Association of Marker with Enhanced Metabolic Characteristics In a preliminary study to determine which allele is associated with which trait and in which breeds, the genotypes of several lines of animals were correlated with days to 110 kg, backfat measurements, daily gains, and average daily feed intake. The pigs used in the study were from lines from Pig Improvement Company (PIC).
Data was accumulated using the PCR test described supra for the I and 2 allele of the MC4R gene. The collected data is summarized in Tables 3-8 below.
According to the results, allele 1 is the significantly leaner allele (see P2 backfat measurements) in all lines except in Chinese pigs where it is the fat allele.
Allele 2 is associated with significantly faster rate of gain (test daily gain) in the tested commercial lines. Overall allele 1 is associated with lower feed intake.
Number of observations MC4R L02 L03 L19 L65 Overall L95 genotype Total 721 MC4R genotype:
11 = homozygous allele 1 12 = heterozygous 1 o 22 = homozygous allele 2 Number of observations (males/femalesl MC4R L02 L03 L19 L65 Overall L95 genotype DaXs to 110kg MC4R L02 L03 L19 L65 Overall L95 genotype 11 169.7 172.4 169.6 168.5 219.1 12 170.2 171.5 165.0 171.2 168.7 212.2 22 165.3 173.4 162.9 170.3 167.1 211.4 P<.23 P<.75 P<.15 P<.76 P<.31 P<.27 P2 backfat (mm) MC4R L02 L03 L19 L65 Overall L95 Genotype 11 10.8 11.9 9.7 11.1 22.8 12 11.3 12.5 12.2 10.5 11.8 21.5 22 12.1 12.7 12.6 10.7 12.1 20.3 P<.10 P<.43 P<.34 P<.17 P<.006 P<.17 Test daily gain l,gm/dl MC4R L02 L03 L19 L65 Overall L95 genotype 11 882.2 811.0 881.8 871.9 688.8 12 891.2 820.5 875.6 873.0 876.3 676.2 22 969.1 819.5 906.7 906.2 906.9 692.5 P<.01 P<.96 P<.05 P<.24 P<.006 P<.66 Average daily feed intake (k~/d), bo r only. except L95 which was eilts only MC4R L02 L03 L19 L65 Overall L95 genotype 11 2.31 1.78 1.75 1.89 2.05 12 2.11 1.90 1.97 1.90 1.96 2.03 22 2.15 1.97 2.00 1.97 2.02 2.08 P<.84 P<.14 P<.56 P<.14 P<.16 P<.36 A Missense Variant of the Porcine Melanocortin-4 Receptor (MC4R) Gene is Associated with Fatness, Growth, and Feed Intake Traits To determine if there was an association of this MC4R polymorphism with phenotypic variation the mutation was tested in a large number of individual animals from several different pig lines. Analyses of growth and performance test records showed significant associations of MC4R genotypes with backfat, growth rate and feed intake in a number of lines. It is probable that the variant amino acid residue of the MC4R mutation causes a significant change of the MC4R function. These results support the functional significance of a pig MC4R missense mutation and suggest that comparative genomics based on model species may be equally important for application to farm animals as they are for human medicine.
Identification of mutations in the leptin and the leptin receptor has provided some information on genetic components involved in the regulation of energy balance (Zhang et al. 1994; Tartaglia et al. 1995). Genetic studies using animal models have facilitated the identification of major genetic causes of obesity (Andersson 1996; Pomp 1997;
Giridharan 1998). Furthermore, several other genes involved in the neural signaling pathway of energy homeostasis have been identified (Flier and Maratos-Flier 1998;
Schwartz et al.
1999). Of particular interest among candidate signaling molecules involved in the regulation of energy homeostasis is the melanocortin-4 receptor (MC4R). The response to leptin signaling is a link between food intake and body weight (Seeley et al. 0 -1997; Marsh et al. 1999). Neuropeptide Y (NPY) signaling in the central nervous system is also mediated by the MC4R protein (Kask et al. 1998). Several mutations in including frameshift and nonsense mutations are associated with dominantly inherited obesity in humans (Vaisse et al. 1998; Yeo et al. 1998). Some other MC4R
missense mutations in humans have also been identified (Gotoda et al. 1997; Hinney et al. 1999) but the functional significance of these mutations has not been characterized.
Selection based on growth characteristics has been of great importance to the pig 1 o industry because of costs associated with feeding and consumer preference for lean meat.
Efficient genetic improvement in these quantitative traits may be augmented through the use of marker assisted selection (MAS) using high density genetic maps (Dekkers and van Arendonk 1998; Rothschild and Plastow 1999). An important tool in this process is comparative mapping using the well-developed human and mouse gene maps, which assist in the identification of corresponding genomic regions or major genes controlling growth and performance traits in the pig. Biological understanding of complex traits in human or model species offers an alternative approach to identify genes responsible for the traits of economic interest in livestock. Several quantitative trait loci (QTL) linkage scans using phenotypically divergent breeds and candidate gene analyses have been successfully conducted for fatness and growth traits (Yu et al. 1995; Casas-Carrillo et al.
1997; Knorr et al. 1997; Knott et al. 1998; Rohrer et al. 1998; Wang et al. 1998; Paszek et al. 1999), but no individual genes with major effects on growth and perfonnance traits have yet been established for commercial populations. The role of MC4R in feed intake and obesity suggests it may be an important genetic marker for the growth-related traits in the pig.
Materials and Methods Animals. Pigs were raised under normal production conditions under the care of PIC employees in nucleus farms in the United States and Europe. Pigs were put on the performance test at approximately 70 days of age and taken off test after 13 weeks. At the end of the trial backfat was measured ultrasonically in real time (B mode) at the 10' rib 2 cm from the centerline. Average daily gain (growth) over the test period was calculated as weight gained divided by days on test. Days to 110 kg market weight was estimated using standard procedures and feed intake was measured using individual electronic measurement equipment.
PCR amplification of a nig MC4R PnP fragment, Primers were designed from homologous regions of human and rat MC4R sequences (GenBank accession no.
s77415 and u67863, respectively). The primers were: forward primer: 5'-TGG CAA TAG
CCA
AGA ACA AG-3' (SEQ. ID NO:6) and reverse primer: 5'-CAG GGG ATA GCA ACA
GAT GA-3' (SEQ. ID NO:7). The PCR reaction was performed using 12.5 ng of porcine genomic DNA, lx PCR buffer, 1.5 mM MgC12, 0.125 mM dNTPs, 0.3 mM of each primer, and 0.35 U Taq DNA polymerase (Promega) in.a lO L final volume. The conditions for PCR were as follows: 2 min at 94 C; 35 cycles of 30 s at 94 C, 1 min at 56 C, 1 min 30 s at 92 C, and a final 15 min extension at 72 C in a Robocycler (Stratagene, La Jolla, CA).
Sequencing and mutation detection. Sequencing of the PCR products from several individual pigs of different breeds was conducted and the sequences were compared to detect any nucleotide change. Sequencing was performed on an ABI sequencer 377 (Applied Biosystems). The porcine MC4R sequence has been submitted to GenBank, and has accession number AF087937. The sequence analysis revealed one nucleotide substitution situated within a Taql restriction enzyme recognition site (Kim et al. 1999). A
set of primers was then designed to generate a smaller MC4R gene fragment, which contained only one informative TaqI restriction site to specify the polymorphic site and to facilitate the PCR-RFLP test. These primers were: forward 5'-TAC CCT GAC CAT
CTT
GAT TG-3' (SEQ. ID NO:10) and reverse: 5'-ATA GCA ACA GAT GAT CTC TTT G-3' (SEQ. ID NO:11).
Statistical analysis. Analysis of variance procedures were used with a mixed model that accounted for the fixed effects of farm, test period, sex of the animal, the MC4R
genotype and site (random). All animals in lines of American/European descent (Lines A-D) were pooled for the overall analysis and in this analysis line of origin was included.
Mean effects were estimated for each genotype and are presented in Tables 9-15. Overall F
tests were used to determine level of significance.
Results Identification of a missense mutation in the pjg MC4R gene. The MC4R gene consists of approximately 1 kb of coding sequence contained within a single exon. About 750 bp of a pig MC4R gene fragment was produced by PCR (Kim et al. 1999). The sequence of the PCR product confirmed that the PCR product is the MC4R gene with 92.2% and 97.6% identities at nucleotide and the amino acid levels, respectively, to the human MC4R sequence. Multiple alignments of the sequences from individual animals of several breeds identified a single nucleotide substitution (G->A; Fig. 5). The polymorphism revealed a missense mutation that replaces aspartic acid (GAU) with asparagine (AAU) at the position identical to amino acid 298 of human MC4R
protein. To confirm this base change, we designed pig-specific primers flanking the polymorphic site and analyzed the polymorphism as a TaqI PCR-RFLP gel (Fig. 6). Figure 6 shows a Taql digestion of the PCR product analyzed by agarose-gel electrophoresis. Allele I
produced 156 and 70 bp fragments and allele 2 produced a 226 bp fragment as the PCR-RFLP. The heterozygote has both allele I and 2 fragments. Molecular marker (M) and MC4R
genotypes are indicated at the top of each lane.
The MC4R missense mutation is within a highly conserved region a_mong melanocortin recentors (MCR). The MCR is a subfamily of G-protein coupled receptors (GPCR) containing certain conserved structural elements common to most other GPCRs, but overall amino acid identities between MCR and other GPCRs are low (Tatro 1996). A
multiple-alignment of the predicted amino acid sequences of the pig MC4R with proteins from other species, other MCR proteins, or representative GPCRs showed that the aspartic acid found at position 298 of the seventh transmembrane domain is very highly conserved in the MCR proteins (Fig. 7). It is interesting to note, however, that this position is occupied by asparagine in most other GPCRs. The MCR proteins show 40-80%
amino acid identity with each other (Tatro 1996), but the second intracytoplasmic loop and the seventh transmembrane domain are highly conserved among MCR proteins (Gantz et al.
1993). Some of the relationships between MCR structure and function have been discovered by the studies of natural and experimental mutations in humans and mice .
(Robbins et al. 1993; Valverde et al. 1995; Frandberg et al. 1998). These studies indicate that some mutations in highly conserved regions cause structural changes and alter the function of the receptor. The Asp298Asn substitution mutation could have an effect on the function of the receptor. However, this will require further testing but it is known that change of the homologous residue in MC1R (Asp294His) is associated with fair skin and red hair in humans (Valverde et al. 1995).
The MC4R missense mutation is associated yvith obesitv-zelatPd traits To investigate the effects of the missense mutation, the relationship of MC4R
genotypes was analyzed for the effects on variation in growth rate, backfat, and feed consumed in over 1,800 animals from several commercial pig lines from PIC, an international pig breeding company. The animals were from closed commercial lines of European/American breeds (Lines A-D) together with a line originating from a cross between a European and a Chinese breed (Line E). In lines A-D significant associations of the MC4R
genotypes were found for all perfonmance traits. The animals homozygous for allele 1 had on average significantly less backfat (P <.001), lower daily gain (P <.001), and lower feed intake(P <
.01) than those of the homozygous 22 genotype animals (Tables 11, 13, & 15).
Overall, pigs with the 11 genotype had approximately 9% less backfat than pigs with the genotype (Table 11), whereas pigs with the 22 genotype grow significantly faster (37g/day) than pigs with the 11 genotype (Table 13). These results appear to be a function of appetite because the 22 genotype animals consume considerably more feed (Table 15). The association between the missense variant of the MC4R gene and related performance traits is clearly established in European/American breeds. Although the number of tested animals is much smaller, these results were not seen in the considerably fatter Chinese crossed line (Line E). Interestingly, line E shows a trend for backfat in the opposite direction to that observed in the other lines (Table 11).
Discussion The present study clearly demonstrates that the porcine MC4R missense mutation-is -significantly associated with several performance traits in pigs. Allele 1 representing Asp298, the well conserved amino acid within other MCR subtypes and other species MC4R, was associated with less backfat thickness, slower growth rate, and lower feed intake and allele 2 representing Asn298 was associated with fatter, higher feed intake, and faster growing animals. As the highly conserved residues in the melanocortin receptor proteins have important roles for ligand binding or intracellular signal transmission (Tatro 1996), the MC4R variants might exert functionally distinct abilities in the regulation of food intake and body weight. Further testing of this hypothesis will provide important insights into the structural basis of MCR function and a molecular target for the treatment of human obesity.
Allele I was associated with the fattest animals in Line E, which was derived by crossing a Chinese Large White breed with a line of Meishan origin. This is surprising given that the mutation causes a significant amino acid change in a well-conserved region.
The result may be due to sampling. However, if we assume that this result will be significant when more results are added there are several possible explanations. One possibility could be the difference in the background gene effects (epistasis). As growth and fatness are complex polygenic traits, it is certainly possible that the Chinese breed has some distinct allelic interactions derived from several hundred years of isolation and these putative interaction(s) might create variation in polygenic traits within crosses between widely different lines (Frankel and Schork 1996). Several QTL analyses have been conducted for fatness and growth traits using divergent lines (Cases-Carrillo et al. 1997;
Knott et al. 1998; Rohrer et al. 1998; Wang et al. 1998; Paszek et al. 1999), but QTL have not been reported near the C4R locus, which maps to chromosome 1 at approximately 80 cm on the linkage map (data not shown). It may mean that the epistatic effects of the MC4R alleles suggested in Line E have made it difficult to observe the MC4R
locus in most QTL experiments which have involved crosses between Chinese and European/American lines. It is likely that the effect of some alleles will be variable in the different backgrounds and hard to detect in QTL experiments involving genetically divergent breeds.
The effect of MC4R variant will possibly be explained by further studies on the biological effect caused by this mutation in other pig breeds and lines.
However, given the -strong relationship of MC4R variants to leanness, growth and feed intake, this mutation could be used immediately for merker assisted selection (Meuwissen and Goddard 1996) to develop lines of pigs to satisfy particular customer requirements. For instance, in sow lines where appetite is normally decreased after farrowing, selection for the MC4R 2 allele could help improve feed intake. Furthermore, in some lines deemed to be too fat, selection for allele 1 could be employed and in lines that were considered too slow growth allele 2 selection could be also employed. Therefore, genotyping for the MC4R mutation in pig breeding lines will improve the selection efficiency of feed related production traits including growth and leanness. The candidate gene approach has also been used for investigating the role of the porcine leptin gene (Jiang and Gibson 1999).
However, in the leptin case, although there was evidence for an association between a leptin polymorphism and backfat depth in a cross between a commercial breed and an unimproved line, there was no clear association in the different commercial lines tested (Jiang and Gibson 1999).
Therefore, it should not be assumed that since one fmds a gene that one can assume a relationship exists. In contrast, with MC4R we have determined that variation in this candidate gene can explain significant variation for backfat, growth rate, and feed intake in commercial lines of pigs. These results with MC4R illustrate the potential value of comparative genetic analyses using candidate genes in livestock genomics.
Number of observations (males/females/totals) for Days to 110 kg and backfat MC4 LINE A LINE B LINE C LINE D Total Line E
R
Days to 110kg MC4 LINE A LINE B LINE C LINE D Total Line E
R
11 166.3+/-0.8 168.4+/-1.4 170.0+/-2.4 167.9+/-0.9 219.1+/-4.8 12 165.6+/-0.9 166. 8+/-1.1 163.9+/-1.0 170.2+/-1.8 166.9+/-0.8 212. 2+/-3 .4 22 162. 3+/-2.3 166. 8+/-1. 5 161. 5+/-0. 8 167. 0+/-1.9 164.6+/-0.9 211.4+/-4.0 P <.24 P <.47 P <.007 P <.10 P <.001 P <.27 10t' rib Backfat (mm) MC4 LINE A LINE B LINE C LINE D Total Line E
R
11 10.7+/-0.2 12.1+/-0.2 9.8+/-0.5 11.1+/-0.2 22.8+/-1.2 12 11.2+/-0.2 12. 5+/-0.2 12.3+/-0.2 10.5+/-0.4 11.6+/-0.2 21.5+/-0.9 22 12. 5+/-0. 5 12. 6+/-0.3 12.7+/-0.2 10.9+/-0.4 12.0+/-0.2 20.3+/-1.0 P <.02 P <.31 P <.06 P <.05 P<.001 P <.17 Number of observations (males/females/totals for Test dailyg~
MC4 1 LINE A LINE B LINE C LINE D Total Line E
R
Test daily gain ( dav) MC4 LINE A LINE B LINE C LINE D Total Line E
R
11 892.6+/-10.4 841.7+/-13.8 882.2+/-18.4 871.9+/-10.2 688.8+/-24.5 12 913.3+/-11.6 868.4+/-12.1 882.2+/-12.9 883.7+/-14.3 885.1+/-8.9 676.2+/-17.6 22 982.8+/-22.8 862.4+/-15.1 913.4+/-10.5 904.6+/-15.1 908.8+/-9.3 692.5+/-20.4 P <.001 P <.28 P <.006 P <.20 P <.001 P <.66 Number of observations (males/females/total) for average daily feed intake MC4R LINE A LINE B LINE C LINE D Total Line E
Average daily feed intake (kg/day). boars only excent LINE E which was gilts onlv MC4 LINE A LINE B LINE C LINE D Total Line E
R
11 2.31+/-0.2 1.78+/-0.09 1.75+/-0.06 1.94+/-0.07 2.05+/-0.10 12 2.11+/-0.3 1.90+/-0.07 1.97+/-0.10 1.90+/-0.07 2.03+/-0.06 2.03+/-0.07 22 2.15+/-0.4 1.97+/-0.06 2.00+/-0.07 1.97+/-0.08 2.11+/-0.06 2.08+/-0.08 P <.84 P <.14 P <.56 P <.14 P <.01 P <.36 Having described the invention with reference to particular compositions, theories of effectiveness, and the like, it will be apparent to those of skill in the art that it is not intended that the invention be limited by such illustrative embodiments or mechanisms, and that modifications can be made without departing from the scope or spirit of the invention, as defined by the appended claims. It is intended that all such obvious modifications and variations be included within the scope of the present invention as =-defined in the appended claims. The claims are meant to cover the claimed components and steps in any sequence which is effective to meet the objectives there intended, unless the context specifically indicates to the contrary.
Andersson LB (1996) "Genes and obesity", Ann Med., 28:5-7.
Arden KC (1990). "The Receptors for Prolactin and Growth Hormone are Localized in the same Region of Human Chromosome 5", Cylogenet. Cell Genet. 53:161-165.
Barinaga M (1996). "Researchers Nail Down Leptin Receptor", Srien 271:913.
Bray GA (1978). Pyysio . Rev. 59, 719-809.
Casas-Carillo E (1997) "Mapping genomic regions associated with growth rate in pigs", I
AnimSci 75:2047-2053.
Chajlani V, "Molecular Cloning of a Novel Human Melanocortin Receptor", Riochem.
Biophvs. Res. Commun., 195, 866-873.
Chen H (1995). "Evidence that the diabetes gene encodes the leptin receptor:
Identification of a mutation in the leptin receptor gene in db/db mice", cAU 84, 491-495.
Chevalet C (1996). CABIOS. In Press.
Chua SC (1996). $sjepc 271,994-996.
Chung WK (1996). Genome Res. 6, 431-438.
Cioffi JA (1996). Nature Med. 2, 585-589.
Cybulsky MI (1991). "Gene Structure, Chromosomal Location, and Basis for Altera.ative mRNA Splicing of the Human VCAM1 Gene". Proc. Nat. Acad. Sci. 88:7859-7863.
Dekkers JCM (1998) "Optimizing selection for quantitative traits with information on an identified locus in outbred population", Genet R 71:257-275.
Flier JS (1998), "Obesity and the hypothalamus: Novel peptides for new pathways", ~
92:437-440.
Frandberg P (1997) "Glutamine2's and arginen in human melanocortin 5 receptor determines its low affinity to MSH",13iochem Biophys Res ConLmLn 236:489-492.
Frankel WN (1996) "Who's afraid of epistasis?" Nat Ggng~ 14:371-373.
Gantz I(1993a) "Molecular Cloning of a Novel Melanocortin Receptor",1. Biol.
Chem. -268, 8246-8250.
Gantz (1993) "Molecular Cloning, Expression in Gene Localization of a Fourth Melanocortin Receptor", J. Biol. Chem. 268, 15174-15179.
Gantz (1994) "Molecular Cloning Expression and Characterization of a Fifth Melanocortin Receptor", Biochem. Biophys. Res. Comm., 200, 1214-1220.
Giridharan NV (1998) "Animal models of obesity and their usefulness in molecular approach to obesity", Indian J Med res 108:225-242.
Gotoda T (1997) "Molecular screening of the human melanocortin-4 receptor gene:
identification of a missense variant showing no association with obesity, plasma glucose, or insulin" Diabetologia 40:976-979.
Goureau A (1996). Sienomics. In Press.
Griffon N (1994) "Molecular Cloning and Characterization of the Rat Fifth Melanocortin Receptor", Biochem. Biophys. Res. Comm., 200, 1007-1014.
Helm J (1994) "Rapid Communication: SacI Restriction Fragment Length Polymorphism with a Porcine Vascular Cell Adhesion Molecule 1(VCAM1) cDNA Fragment", L
Anim. Science 72:2764.
Hinney A (1999) "Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans" J Clin Endocrinol Metab 84:1483-1486.
Huszar (1997) "Targeted disruption of the Melanocortin-4 Receptor Results in /Obesity in Mice", Ct1188:131-141.
Kask A (1998) "Evidence that orexigenic effects of melanocortin 4 receptor antagonist HS014 are mediated by neuropeptide Y" Biochem Biophys Res Commu~n 248:245-249.
Kim KS (1999) "Rapid Communication: Linkage and physical mapping of the porcine Melanocortin-4 Receptor (MC4R gene" J Anim Sci (submitted).
Knorr C (1997) "Associations of GH gene variants with performance traits in F2 generations of European wild boar, Pietrain and Meishan pigs" Anim Genet 28:124-128.
Knott SA (1998) "Multiple*marker mapping of quantitative trait loci in a cross between outbred wild boar and large white pigs" Genetics 149:1069-1680. -Labbe O(1994) "Molecular Cloning of a Mouse Melanocortin-5 Receptor Gene Widely Expressed in Peripheral Tissues", Biochemistrv, 33, 4543-4549.
Lee GH (1996). ature 379, 632-635.
Lu Dongsi "Agouti Protein is an Antagonist of the Melanocyte-Stimulating Hormone Receptor" Letters to Nature.
Marsh DJ (1999) "Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides" Nat Genet 21:119-122.
Messer L, (1996a) "Mapping and Investigation of Candidate Genes for Litter Size in French Large White Pigs" ISAG Proceedi= (submitted).
Messer L(1996b) "Linkage Mapping of the Retinoic Acid Receptor Gamma (RARG) Gene to Porcine Chromosome 5". Anim. Genet. (in press).
Messer L (1996c) "Linkage mapping of the Retinol Binding Protein 4 (RBP4) Gene to Porcine Chromosome 14". Mammal. Genome (in press).
Meuwissen THE (1996) "The use of marker haplotypes in animal breeding schemes"
Genet Sel Evol 28:161-176.
Montjoy KG (1992) "The Cloning of a Family of Genes that Encode the Melanocortin Receptors", i n 257, 1248-1251.
Montjoy KG (1994) "Localization of the Melanocortin-4 Receptor (MC4-R) In Neuroendocrine In Autonomic Control Circuits in the Brain" Mol. Endocrinol. 8, 1298-1308.
Paszek A (1996) "Genomic Scan for Quantitative Trait Loci in Swine." Proceed.
Midwest.
ASAS Meeting, p. 24.
Paszek AA (1999) "Interval mapping of growth in divergent swine cross" Mamm Genome 10:117-122.
Phillips M (1996) "Leptin Receptor Missense Mutation in the Fatty Zucker Rat", Nature Genetics 13:18-19.
Pomp D (1997) "Genetic dissection of obesity in polygenic animal models" Behav Genet 27:285-306.
Robbins LS (1993) "Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function" f&H 72:827-834.
Robic A (1996). Mamm. Genome 7, 438-445.
Rohrer GA (1998) "Identification of quantitative trait loci affecting carcass composition in swine: I. Fat deposition traits" J Anim Sci 76:2247-2254.
Rothschild MF (1996). "The Estrogen Receptor Locus is Associated With a Major Gene for Litter Size in Pigs". PNAS 93: 201-205.
Rothschild MF(1999) "Advances in pig genomics and industry applications"
AgBiotechNet 1:1-8.
1 o Schwartz MW (1999) "Model for the regulation of energy balance and adiposity by the central nervous system" Am J Clin Nutr 69:584-96.
Seeley RJ (1997) "Melanocortin receptors in leptin effects", Nature 390:349.
Tartaglia LA (1995) "Identification and Expression Cloning of a Leptin Receptor" CgE
83:1263-1271.
Tatro JB (1996) "Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides", Neuroimmunomodulation 3:259-284.
Truett GE (1995). Mamm. Genome 6, 25-30.
Vaisse C (1998) "A frameshift mutation in human MC4R is associated with a dominant form of obesity" Nat Genet 20:113-114.
Valverde P (1995) "Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans" NatGenet 11:328-330.
Wang L (1998) "A direct search for quantitative trait loci on chromosomes 4 and 7 in pigs"
J Anim Sci 76:2560-2567.
Warner CM (1991). "The Swine Major Histocompatibility Complex (SLA)" in Immunogenetics of the MHC, VCH Publishers, NY, NY, pp. 368-397.
Winick JD (1996). Genomics 36, 221-222.
Xy Y (1994) "Identification of the Ped Gene at the Molecular Level: The Q9 MHC
Class I
Transgene Converts the Ped Slow Phenotype to Ped Fast Phenotype" Biol. Reprod.
51:695-699.
Yeo GS (1998) "A frameshift mutation in MC4R associated with dominantly inherited human obesity" I~a ne 20:111-112.
Yerle M (1996). QjQgenet. Cell Genet. 73, 194-202.
Youngs CR (1993) "Investigation into the Control of Litter Size- in Swine: I.
Comparative --Studies on in vitro Development of Meishan and Yorkshire Preimplantation Embryos" J. Anim. Sci., 1561-1565.
Yu TP (1995) "Association of PIT1 polymorphisms with growth and carcass traits in pigs"
J Anim Sci 73:1282-1288.
Zhang Y (1994) "Positional cloning of the mouse obese gene and its human homologue", Nat 372:425-432.
Ziang ZH (1999) "Genetic polymorphisms in the leptin gene and their association with fatness in four pig breeds" Mamm Genome 12:191-193.
. ~ ' SEQUENCE LISTING
<110> Iowa State University Research Foundation <120> Melanocortin-4 Receptor Gene and Use as a Genetic Marker for Fat Content, Weight Gain, and/or Feed Consumption in Animals <130> 2926/0004 <140> 2,337,495 <141> 1999-07-26 <150> PCT/US99/16862 <151> 1999-07-26 <150> 60/094,287 <151> 1998-07-27 <150> 60/116,196 <151> 1999-01-15 <160> 11 <170> PatentIn Ver. 2.0 <210> 1 <211> 746 <212> DNA
<213> porcine <220>
<221> variation <222> (678) <223> G/A
<400> 1 acaagaatct gcattcaccc atgtactttt tcatctgtag cctggctgtg gctgatatgc 60 tggtgagcgt ttccaatggg tcagaaacca ttgtcatcac cctattaaac agcacggaca 120 cggacgcaca gagtttcaca gtgaatattg ataatgtcat tgactcagtg atctgtagct 180 ccttactcgc ctcaatttgc agcctgcttt cgattgcagt ggacaggtat tttactatct 240 tttatgctct ccagtaccat aacattatga cagttaagcg ggttggaatc atcatcagtt 300 gtatctgggc agtctgcacg gtgtcgggtg ttttgttcat catttactca gatagcagtg 360 ctgttattat ctgcctcata accgtgttct tcaccatgct ggctctcatg gcttctctct 420 atgtccacat gttcctcatg gccagactcc acattaagag gatcgccgtc ctcccaggca 480 ctggcaccat ccgccaaggt gccaacatga agggggcaat taccctgacc atcttgattg 540 gggtctttgt ggtctgctgg gcccccttct tcctccactt aatattctat atctcctgcc 600 cccagaatcc atactgtgtg tgcttcatgt ctcactttaa tttgtatctc atcctgatca 660 tgtgtaattc catcatcgat cccctgattt atgcactccg gagccaagaa ctgaggaaaa 720 ccttcaaaga gatcatctgt tgctat 746 <210> 2 <211> 840 <212> DNA
<213> Homo sapiens <400> 2 atatcttagt gattgtggca atagccaaga acaagaatct gcattcaccc atgtactttt 60 tcatctgcag cttggctgtg gctgatatgc tggtgagcgt ttcaaatgga tcagaaacca 120 ttatcatcac cctattaaac agtacagata cggatgcaca gagtttcaca gtgaatattg 180 ataatgtcat tgactcggtg atctgtagct ccttgcttgc atccatttgc agcctgcttt 240 caattgcagt ggacaggtac tttactatct tctatgctct ccagtaccat aacattatga 300 cagttaagcg ggttgggatc agcataagtt gtatctgggc agcttgcacg gtttcaggca 360 ttttgttcat catttactca gatagtagtg ctgtcatcat ctgcctcatc accatgttct 420 tcaccatgct ggctctcatg gcttctctct atgtccacat gttcctgatg gccaggcttc 480 acattaagag gattgctgtc ctccccggca ctggtgccat ccgccaaggt gccaatatga 540 agggagcgat taccttgacc atcctgattg gcgtctttgt tgtctgctgg gccccattct 600 tcctccactt aatattctac atctcttgtc ctcagaatcc atattgtgtg tgcttcatgt 660 ctcactttaa cttgtatctc atactgatca tgtgtaattc aatcatcgat cctctgattt 720 atgcactccg gagtcaagaa ctgaggaaaa ccttcaaaga gatcatctgt tgctatcccc 780 tgggaggcct ttgtgacttg tctagcagat attaaatggg gacagagcac gcaatatagg 840 <210> 3 <211> 746 <212> DNA
<213> porcine <400> 3 acaagaatct gcattcaccc atgtactttt tcatctgtag cctggctgtg gctgatatgc 60 tggtgagcgt ttccaatggg tcagaaacca ttgtcatcac cctattaaac agcacggaca 120 cggacgcaca gagtttcaca gtgaatattg ataatgtcat tgactcagtg atctgtagct 180 ccttactcgc ctcaatttgc agcctgcttt cgattgcagt ggacaggtat tttactatct 240 tttatgctct ccagtaccat aacattatga cagttaagcg ggttggaatc atcatcagtt 300 gtatctgggc agtctgcacg gtgtcgggtg ttttgttcat catttactca gatagcagtg 360 ctgttattat ctgcctcata accgtgttct tcaccatgct ggctctcatg gcttctctct 420 atgtccacat gttcctcatg gccagactcc acattaagag gatcgccgtc ctcccaggca 480 ctggcaccat ccgccaaggt gccaacatga agggggcaat taccctgacc atcttgattg 540 gggtctttgt ggtctgctgg gcccccttct tcctccactt aatat+tctat atctcctgcc 600 cccagaatcc atactgtgtg tgcttcatgt ctcactttaa tttgtatctc atcctgatca 660 tgtgtaattc catcatcaat cccctgattt atgcactccg gagccaagaa ctgaggaaaa 720 ccttcaaaga gatcatctgt tgctat 746 <210> 4 <211> 311 <212> PRT
<213> Homo sapiens <220>
<221> miscfeature <222> () . . () <223> "X" can be any amino acid <400> 4 Gin Leu Phe Val Ser Pro Glu Val Phe Val Thr Leu G:Ly Val Ile Ser Leu Leu Glu Asn Ile Leu Val Ile Val Ala Ile Ala Lys Asn Lys Asn Leu His Ser Pro Met Tyr Phe Phe Ile Cys Ser Leu A1.a Val Ala Asp Met Leu Val Ser Val Ser Asn Gly Ser Glu Thr Ile Ile Ile Thr Leu Leu Asn Ser Thr Asp Thr Asp Ala Gin Ser Phe Thr Val Asn Ile Asp Asn Val Ile Asp Ser Val Ile Cys Ser Ser Leu Leu A=La Ser Ile Cys Ser Leu Leu Ser Ile Ala Val Asp Arg Tyr Phe Thr I}.e Phe Tyr Ala Leu Gln Tyr His Asn Ile Met Thr Val Lys Arg Val G:1y Ile Ser Ile 115 120 1:25 Ser Cys Ile Trp Ala Ala Cys Thr Val Ser Gly Ile Leu Phe Ile Ile Tyr Ser Asp Ser Ser Ala Val Ile Ile Cys Leu Ile Thr Met Phe Phe Thr Met Leu Ala Leu Met Ala Ser Leu Tyr Val His Met Phe Leu Met Ala Arg Leu His Ile Lys Arg Ile Ala Val Leu Pro G.1y Thr Gly Ala Ile Arg Gln Gly Ala Asn Met Lys Gly Ala Ile Thr Leu Thr Ile Leu Ile Gly Val Phe Val Val Cys Trp Ala Pro Phe Phe Leu His Leu Ile Phe Tyr Ile Ser Cys Pro Gin Asn Pro Tyr Cys Val Cys Phe Met Ser His Phe Asn Leu Tyr Leu Ile Leu Ile Met Cys Asn Ser Ile Ile Asp Pro Leu Ile Tyr Ala Leu Arg Ser Gln Glu Leu Arg Lys Thr Phe Lys Glu Ile Ile Cys Cys Tyr Pro Leu Gly Gly Leu Cys Asp Leu Ser Ser Arg Tyr Ala Pro Pro Glu Asn Asp Ile Xaa Val Ile Cys Asn Phe Ile Asp Glu Asn Thr Ile Ala Leu <210> 5 <211> 248 <212> PRT
<213> porcine <400> 5 Lys Asn Leu His Ser Pro Met Tyr Phe Phe Ile Cys Ser Leu Ala Val Ala Asp Met Leu Val Ser Val Ser Asn Gly Ser Glu Thr Ile Val Ile Thr Leu Leu Asn Ser Thr Asp Thr Asp Ala Gln Ser Phe Thr Val Asn 35 40 4; 5 Ile Asp Asn Val Ile Asp Ser Val Ile Cys Ser Ser Leu Leu Ala Ser Ile Cys Ser Leu Leu Ser Ile Ala Val Asp Arg Tyr Phe Thr Ile Phe . ~ , Tyr Ala Leu Gln Tyr His Asn Ile Met Thr Val Lys A:rg Val Gly Ile Ile Ile Ser Cys Ile Trp Ala Val Cys Thr Val Ser G:ly Val Leu Phe Ile Ile Tyr Ser Asp Ser Ser Ala Val Ile Ile Cys Leu Ile Thr Val Phe Phe Thr Met Leu Ala Leu Met Ala Ser Leu Tyr Val His Met Phe Leu Met Ala Arg Leu His Ile Lys Arg Ile Ala Val Leu Pro Gly Thr Gly Thr Ile Arg Gln Gly Ala Asn Met Lys Gly Ala I:1e Thr Leu Thr Ile Leu Ile Gly Val Phe Val Val Cys Trp Ala Pro Phe Phe Leu His Leu Ile Phe Tyr Ile Ser Cys Pro Gln Asn Pro Tyr Cys Val Cys Phe Met Ser His Phe Asn Leu Tyr Leu Ile Leu Ile Met Cys Asn Ser Ile Ile Asn Pro Leu Ile Tyr Ala Leu Arg Ser Gln Glu Leu Arg Lys Thr Phe Lys Glu Ile Ile Cys Cys Tyr <210> 6 <211> 20 <212> DNA
<213> porcine <400> 6 tggcaatagc caagaacaag 20 <210> 7 <211> 20 <212> DNA
<213> porcine <400> 7 caggggatag caacagatga 20 <210> 8 <211> 18 <212> DNA
<213> porcine <400> 8 ttaagtggag gaagaagg 18 <210> 9 <211> 19 <212> DNA
<213> porcine <400> 9 cattatgaca gttaagcgg 19 <210> 10 <211> 20 <212> DNA
<213> porcine <400> 10 taccctgacc atcttgattg 20 <210> 11 <211> 22 <212> DNA
<213> porcine <400> 11 atagcaacag atgatctctt tg 22
Melanocortin 4 Receptor PCR-RFLP Test - TaqI polymorphism and Genetic Linkage Mapping of MC4R Gene Primers:
Primers were designed from homologous regions of human and rat MC4R
sequences (Genbank Accession No. s77415 and u67863, respectively). These primers were used to amplify a 750-bp sequence of the porcine MC4R gene.
MC4R1: 5' TGG CAA TAG CCA AGA ACA AG 3' (SEQ ID NO:6) MC4R4: 5' CAG GGG ATA GCA ACA GAT GA 3' (SEQ ID NO:7) PCR Conditions:
Mix 1: l OX Promega Buffer 1.0 L
mM MgCl2 0.6 L
dNTPs mix (2.5mM each) 0.5 L
25 pmoV L MC4R1 0.1 L
25 pmol/ L MC4R4 0.1 L
dd sterile H20 7.5 L
Taq Polymerase (5 U/ L) 0.07 L
Genomic DNA (12.5 ng/ L) 1.0 L
Ten L of Mix 1 and DNA were combined in reaction tube, then overlaid with mineral oil. The following PCR program was run: 94 C for 2 min.; 35 cycles of 94 C for 20 30 sec.; 58 C 1 min., and 72 C 1 min. 30 sec.; followed by a final extension at 72 C for 15 min.
Five l of the PCR reaction product was checked on a standard 1% agarose gel to confirm amplification success and clean negative control. Product size is approximately , 750 base pairs. Digestion was performed by the following procedure.
TaqI Digestion Reaction 10 IaL reaction PCR product 5.0 L
l OX TaqI NE Buffer 1.0 L
BSA (10mg/ml) 0.1 L
Taql enzyme (20 U/ L) 0.5 L
dd sterile H20 3.4 L
A cocktail of the buffer, enzyme, BSA, and water was made. Five L was added to each reaction tube containing the DNA. The mixture was then incubated at 65 C
for at least 4 hours to overnight. Loading dye was mixed with the digestion reaction and the total volume was loaded on a 3% agarose gel. The major bands for allele I are about 466, 225, and 76 bp. The allele 2 genotype bands are 542 and 225 bp. The heterozygote genotype has both allele I and allele 2.
R t The amplified PCR product is about 750 bp. The sequence of the PCR product confirmed that the PCR product is MC4R gene with 97.6%, and 92.2% identities at the amino acid and DNA level, respectively, to corresponding human sequences. (see Figs. 2 and 3).
The Taql digestion of the PCR product produced allelic fragments of 466, 225, and 76 bp (allele 1), or 542 and 225 bp (allele 2). The heterozygote genotype has both types of alleles. Mendelian inheritance was observed in three three-generation international reference families, which were used to map this gene by linkage analysis.
The polymorphism between allele 1 and allele 2 resulting from a G-* A
transition at position 678 of the PCR product revealed a missense mutation of Aspartic acid codon (GAU) into Asparagine codon (AAU) at position 298 amino acid of MC4R protein.
(See Figure 1, SEQ ID NO:1).
Allele frequencies were determined by genotyping of DNA samples from a small number of animals from different breeds (Table 1). Allele I was observed with a frequency of 1 in Meishan, but was not observed or observed at very low frequency in Hampshire and Yorkshire. The frequencies of allele 1 in Landrace and Chester White were 0.5, respectively.
Figures 2 and 3 illustrate the differences between the DNA and amino acid sequences of the human and porcine MC4R gene (SEQ ID NOS:2-5).
The Frequencv of Allele 1 in Different Pig Breeds Breed # Animals Freq. Allele 1 Meishan 8 1 Large White 8 0.56 Yorkshire 6 0.08 Hampshire 5 0 Landrace 4 0.5 Chester White 4 0.5 Minzu 2 1 Wild Boar 2 1 Linkage Analyses Two-point and multi-point linkage analyses were performed on the genotypes of international reference families. See Figs. 4a-4c. The data were analyzed by using the CRI-MAP program. MC4R was significantly linked to several markers on porcine chromosome (SSC) 1. The most closely linked markers (recombination fraction and LOD
score in parentheses) are S0331 (0.02, 21.97), BHT0433 (0.02, 21.32), and S0313 (0.00, 17.76) by two-point linkage analysis. A multi-point linkage analysis produced the best map order of markers and MC4R (with distance in Kosambi cM): KGF-5.8-CAPN3-2.5-MEF2A-6.1-MC4R-5.6-S0313.
Somatic cell hybrid panel of pig and rodent was used to assign MC4R to a cytogenetic region. PCR products from pig specific primers were amplified in clones 7, $_ 16, 18, and 19. MC4R was localized to SSCIq 22-27.
MC4R Receptor PCR-RFLP Test using Pig Specific Primers and Genetic Linkage Mapping of the Porcine MC4R Gene PigSnecific Primer Sequences Forward primer: 5'-TTA AGT GGA GGA AGA AGG-3' (SEQ ID NO:8) Reverse primer: 5'-CAT TAT GAC AGT TAA GCG G-3' (SEQ ID NO:9) Method of Detection The PCR reaction was performed using Porcine genomic DNA 12.5 ng 1 x PCR buffer MgCIZ 1.5 mM
dNTP 0.125 mM
Forward primer 0.3 M
Reverse primer 0.3 M
Taq DNA polymerase (Promega) 0.35 U
in a 10 L final volume. The PCR profile included 2 min. at 94 C; 35 cycles of 30 sec. at 94 C, 1 min. at 56 C, 1 min. 30 sec. at 72 C; and 15 min. at 72 C in a Robocycler (Statagene, La Jolla, CA). A 5.0 L aliquot of the PCR products was digested in a total volume of 10 L with 10 U of Taql incubated overnight at 65 C. The digestion products were electrophoresed on a 3% agarose gel.
Description of Pol,ymornhism The TaqI digestion of the PCR product produced fragments of 466, 225, and 76 bR -in allele I and 542 and 225 bp in allele 2. The heterozygous genotype has fragments of both allele 1 and allele 2.
Pattern of Inheritance Autosomal segregation of Mendelian inheritance was observed in three three-generation European PiGMaP families (Archibald et al., 1995).
Allele Frequencies Allele frequencies were determined by genotyping the grandparental animals of the European PiGMaP families and unrelated animals from ISU reference families.
Allele 1 was observed with the following frequencies.
The Frequency of Allele I in Different Pig Breeds Breed # Animals Freq. Allele 1 Meishan 8 1 Large White 8 0.56 Yorkshire 10 0.15 Hampshire 12 0 Landrace 8 0.56 Chester White 8 0.56 Minzu 2 1 Wild Boar 2 1 Chromosomal Location Two-point and multi-point linkage analysis were performed on the genotypes of three PiGMaP families using the CRI-MAP program (Green et al. 1990). MC4R was significantly linked to several markers on porcine chromosome 1(SSC 1). The most closely linked markers (recombination fraction and LOD score in parentheses) are S0331 -(0.02, 21.97), BHT0433 (0.02, 21.32), and S0313 (0.00, 17.76) according to two-point linkage analysis. The best map order of MC4R with respect to other linked markers produced by multi-point linkage analysis is as follows (with distance in Kosambi cM):
KGF-5.8-CAPN3-2.5 -MEF2A-6.1-MC4R-5.6-SO313.
Comments The Melanocortin-4 Receptor is a G protein-coupled, seven-transmembrane receptor expressed in the brain. Huszar et al. (1997) found that inactivation of MC4R gene resulted in a maturity onset obesity syndrome in mice and demonstrated a major role of MC4R protein in the regulation of energy balance. The MC4R gene has been mapped to human chromosome 18q21.3 (Gantz et al., 1993). The localization of MC4R gene to SSC
1 is consistent with previous chromosome painting data indicating synteny between this chromosome and HSA 18 and 15 (Goureau et al., 1996). However, the gene order of several genes previously mapped from HSA 18 and 15 to SSC 1, including CAPN3, KGF, and MEF2A, is not conserved with MC4R. Therefore, mapping of MC4R to SSC 1 may identify an evolutionary breakpoint between HSA 18 and 15 in relation to SSC
1.
Association of Marker with Enhanced Metabolic Characteristics In a preliminary study to determine which allele is associated with which trait and in which breeds, the genotypes of several lines of animals were correlated with days to 110 kg, backfat measurements, daily gains, and average daily feed intake. The pigs used in the study were from lines from Pig Improvement Company (PIC).
Data was accumulated using the PCR test described supra for the I and 2 allele of the MC4R gene. The collected data is summarized in Tables 3-8 below.
According to the results, allele 1 is the significantly leaner allele (see P2 backfat measurements) in all lines except in Chinese pigs where it is the fat allele.
Allele 2 is associated with significantly faster rate of gain (test daily gain) in the tested commercial lines. Overall allele 1 is associated with lower feed intake.
Number of observations MC4R L02 L03 L19 L65 Overall L95 genotype Total 721 MC4R genotype:
11 = homozygous allele 1 12 = heterozygous 1 o 22 = homozygous allele 2 Number of observations (males/femalesl MC4R L02 L03 L19 L65 Overall L95 genotype DaXs to 110kg MC4R L02 L03 L19 L65 Overall L95 genotype 11 169.7 172.4 169.6 168.5 219.1 12 170.2 171.5 165.0 171.2 168.7 212.2 22 165.3 173.4 162.9 170.3 167.1 211.4 P<.23 P<.75 P<.15 P<.76 P<.31 P<.27 P2 backfat (mm) MC4R L02 L03 L19 L65 Overall L95 Genotype 11 10.8 11.9 9.7 11.1 22.8 12 11.3 12.5 12.2 10.5 11.8 21.5 22 12.1 12.7 12.6 10.7 12.1 20.3 P<.10 P<.43 P<.34 P<.17 P<.006 P<.17 Test daily gain l,gm/dl MC4R L02 L03 L19 L65 Overall L95 genotype 11 882.2 811.0 881.8 871.9 688.8 12 891.2 820.5 875.6 873.0 876.3 676.2 22 969.1 819.5 906.7 906.2 906.9 692.5 P<.01 P<.96 P<.05 P<.24 P<.006 P<.66 Average daily feed intake (k~/d), bo r only. except L95 which was eilts only MC4R L02 L03 L19 L65 Overall L95 genotype 11 2.31 1.78 1.75 1.89 2.05 12 2.11 1.90 1.97 1.90 1.96 2.03 22 2.15 1.97 2.00 1.97 2.02 2.08 P<.84 P<.14 P<.56 P<.14 P<.16 P<.36 A Missense Variant of the Porcine Melanocortin-4 Receptor (MC4R) Gene is Associated with Fatness, Growth, and Feed Intake Traits To determine if there was an association of this MC4R polymorphism with phenotypic variation the mutation was tested in a large number of individual animals from several different pig lines. Analyses of growth and performance test records showed significant associations of MC4R genotypes with backfat, growth rate and feed intake in a number of lines. It is probable that the variant amino acid residue of the MC4R mutation causes a significant change of the MC4R function. These results support the functional significance of a pig MC4R missense mutation and suggest that comparative genomics based on model species may be equally important for application to farm animals as they are for human medicine.
Identification of mutations in the leptin and the leptin receptor has provided some information on genetic components involved in the regulation of energy balance (Zhang et al. 1994; Tartaglia et al. 1995). Genetic studies using animal models have facilitated the identification of major genetic causes of obesity (Andersson 1996; Pomp 1997;
Giridharan 1998). Furthermore, several other genes involved in the neural signaling pathway of energy homeostasis have been identified (Flier and Maratos-Flier 1998;
Schwartz et al.
1999). Of particular interest among candidate signaling molecules involved in the regulation of energy homeostasis is the melanocortin-4 receptor (MC4R). The response to leptin signaling is a link between food intake and body weight (Seeley et al. 0 -1997; Marsh et al. 1999). Neuropeptide Y (NPY) signaling in the central nervous system is also mediated by the MC4R protein (Kask et al. 1998). Several mutations in including frameshift and nonsense mutations are associated with dominantly inherited obesity in humans (Vaisse et al. 1998; Yeo et al. 1998). Some other MC4R
missense mutations in humans have also been identified (Gotoda et al. 1997; Hinney et al. 1999) but the functional significance of these mutations has not been characterized.
Selection based on growth characteristics has been of great importance to the pig 1 o industry because of costs associated with feeding and consumer preference for lean meat.
Efficient genetic improvement in these quantitative traits may be augmented through the use of marker assisted selection (MAS) using high density genetic maps (Dekkers and van Arendonk 1998; Rothschild and Plastow 1999). An important tool in this process is comparative mapping using the well-developed human and mouse gene maps, which assist in the identification of corresponding genomic regions or major genes controlling growth and performance traits in the pig. Biological understanding of complex traits in human or model species offers an alternative approach to identify genes responsible for the traits of economic interest in livestock. Several quantitative trait loci (QTL) linkage scans using phenotypically divergent breeds and candidate gene analyses have been successfully conducted for fatness and growth traits (Yu et al. 1995; Casas-Carrillo et al.
1997; Knorr et al. 1997; Knott et al. 1998; Rohrer et al. 1998; Wang et al. 1998; Paszek et al. 1999), but no individual genes with major effects on growth and perfonnance traits have yet been established for commercial populations. The role of MC4R in feed intake and obesity suggests it may be an important genetic marker for the growth-related traits in the pig.
Materials and Methods Animals. Pigs were raised under normal production conditions under the care of PIC employees in nucleus farms in the United States and Europe. Pigs were put on the performance test at approximately 70 days of age and taken off test after 13 weeks. At the end of the trial backfat was measured ultrasonically in real time (B mode) at the 10' rib 2 cm from the centerline. Average daily gain (growth) over the test period was calculated as weight gained divided by days on test. Days to 110 kg market weight was estimated using standard procedures and feed intake was measured using individual electronic measurement equipment.
PCR amplification of a nig MC4R PnP fragment, Primers were designed from homologous regions of human and rat MC4R sequences (GenBank accession no.
s77415 and u67863, respectively). The primers were: forward primer: 5'-TGG CAA TAG
CCA
AGA ACA AG-3' (SEQ. ID NO:6) and reverse primer: 5'-CAG GGG ATA GCA ACA
GAT GA-3' (SEQ. ID NO:7). The PCR reaction was performed using 12.5 ng of porcine genomic DNA, lx PCR buffer, 1.5 mM MgC12, 0.125 mM dNTPs, 0.3 mM of each primer, and 0.35 U Taq DNA polymerase (Promega) in.a lO L final volume. The conditions for PCR were as follows: 2 min at 94 C; 35 cycles of 30 s at 94 C, 1 min at 56 C, 1 min 30 s at 92 C, and a final 15 min extension at 72 C in a Robocycler (Stratagene, La Jolla, CA).
Sequencing and mutation detection. Sequencing of the PCR products from several individual pigs of different breeds was conducted and the sequences were compared to detect any nucleotide change. Sequencing was performed on an ABI sequencer 377 (Applied Biosystems). The porcine MC4R sequence has been submitted to GenBank, and has accession number AF087937. The sequence analysis revealed one nucleotide substitution situated within a Taql restriction enzyme recognition site (Kim et al. 1999). A
set of primers was then designed to generate a smaller MC4R gene fragment, which contained only one informative TaqI restriction site to specify the polymorphic site and to facilitate the PCR-RFLP test. These primers were: forward 5'-TAC CCT GAC CAT
CTT
GAT TG-3' (SEQ. ID NO:10) and reverse: 5'-ATA GCA ACA GAT GAT CTC TTT G-3' (SEQ. ID NO:11).
Statistical analysis. Analysis of variance procedures were used with a mixed model that accounted for the fixed effects of farm, test period, sex of the animal, the MC4R
genotype and site (random). All animals in lines of American/European descent (Lines A-D) were pooled for the overall analysis and in this analysis line of origin was included.
Mean effects were estimated for each genotype and are presented in Tables 9-15. Overall F
tests were used to determine level of significance.
Results Identification of a missense mutation in the pjg MC4R gene. The MC4R gene consists of approximately 1 kb of coding sequence contained within a single exon. About 750 bp of a pig MC4R gene fragment was produced by PCR (Kim et al. 1999). The sequence of the PCR product confirmed that the PCR product is the MC4R gene with 92.2% and 97.6% identities at nucleotide and the amino acid levels, respectively, to the human MC4R sequence. Multiple alignments of the sequences from individual animals of several breeds identified a single nucleotide substitution (G->A; Fig. 5). The polymorphism revealed a missense mutation that replaces aspartic acid (GAU) with asparagine (AAU) at the position identical to amino acid 298 of human MC4R
protein. To confirm this base change, we designed pig-specific primers flanking the polymorphic site and analyzed the polymorphism as a TaqI PCR-RFLP gel (Fig. 6). Figure 6 shows a Taql digestion of the PCR product analyzed by agarose-gel electrophoresis. Allele I
produced 156 and 70 bp fragments and allele 2 produced a 226 bp fragment as the PCR-RFLP. The heterozygote has both allele I and 2 fragments. Molecular marker (M) and MC4R
genotypes are indicated at the top of each lane.
The MC4R missense mutation is within a highly conserved region a_mong melanocortin recentors (MCR). The MCR is a subfamily of G-protein coupled receptors (GPCR) containing certain conserved structural elements common to most other GPCRs, but overall amino acid identities between MCR and other GPCRs are low (Tatro 1996). A
multiple-alignment of the predicted amino acid sequences of the pig MC4R with proteins from other species, other MCR proteins, or representative GPCRs showed that the aspartic acid found at position 298 of the seventh transmembrane domain is very highly conserved in the MCR proteins (Fig. 7). It is interesting to note, however, that this position is occupied by asparagine in most other GPCRs. The MCR proteins show 40-80%
amino acid identity with each other (Tatro 1996), but the second intracytoplasmic loop and the seventh transmembrane domain are highly conserved among MCR proteins (Gantz et al.
1993). Some of the relationships between MCR structure and function have been discovered by the studies of natural and experimental mutations in humans and mice .
(Robbins et al. 1993; Valverde et al. 1995; Frandberg et al. 1998). These studies indicate that some mutations in highly conserved regions cause structural changes and alter the function of the receptor. The Asp298Asn substitution mutation could have an effect on the function of the receptor. However, this will require further testing but it is known that change of the homologous residue in MC1R (Asp294His) is associated with fair skin and red hair in humans (Valverde et al. 1995).
The MC4R missense mutation is associated yvith obesitv-zelatPd traits To investigate the effects of the missense mutation, the relationship of MC4R
genotypes was analyzed for the effects on variation in growth rate, backfat, and feed consumed in over 1,800 animals from several commercial pig lines from PIC, an international pig breeding company. The animals were from closed commercial lines of European/American breeds (Lines A-D) together with a line originating from a cross between a European and a Chinese breed (Line E). In lines A-D significant associations of the MC4R
genotypes were found for all perfonmance traits. The animals homozygous for allele 1 had on average significantly less backfat (P <.001), lower daily gain (P <.001), and lower feed intake(P <
.01) than those of the homozygous 22 genotype animals (Tables 11, 13, & 15).
Overall, pigs with the 11 genotype had approximately 9% less backfat than pigs with the genotype (Table 11), whereas pigs with the 22 genotype grow significantly faster (37g/day) than pigs with the 11 genotype (Table 13). These results appear to be a function of appetite because the 22 genotype animals consume considerably more feed (Table 15). The association between the missense variant of the MC4R gene and related performance traits is clearly established in European/American breeds. Although the number of tested animals is much smaller, these results were not seen in the considerably fatter Chinese crossed line (Line E). Interestingly, line E shows a trend for backfat in the opposite direction to that observed in the other lines (Table 11).
Discussion The present study clearly demonstrates that the porcine MC4R missense mutation-is -significantly associated with several performance traits in pigs. Allele 1 representing Asp298, the well conserved amino acid within other MCR subtypes and other species MC4R, was associated with less backfat thickness, slower growth rate, and lower feed intake and allele 2 representing Asn298 was associated with fatter, higher feed intake, and faster growing animals. As the highly conserved residues in the melanocortin receptor proteins have important roles for ligand binding or intracellular signal transmission (Tatro 1996), the MC4R variants might exert functionally distinct abilities in the regulation of food intake and body weight. Further testing of this hypothesis will provide important insights into the structural basis of MCR function and a molecular target for the treatment of human obesity.
Allele I was associated with the fattest animals in Line E, which was derived by crossing a Chinese Large White breed with a line of Meishan origin. This is surprising given that the mutation causes a significant amino acid change in a well-conserved region.
The result may be due to sampling. However, if we assume that this result will be significant when more results are added there are several possible explanations. One possibility could be the difference in the background gene effects (epistasis). As growth and fatness are complex polygenic traits, it is certainly possible that the Chinese breed has some distinct allelic interactions derived from several hundred years of isolation and these putative interaction(s) might create variation in polygenic traits within crosses between widely different lines (Frankel and Schork 1996). Several QTL analyses have been conducted for fatness and growth traits using divergent lines (Cases-Carrillo et al. 1997;
Knott et al. 1998; Rohrer et al. 1998; Wang et al. 1998; Paszek et al. 1999), but QTL have not been reported near the C4R locus, which maps to chromosome 1 at approximately 80 cm on the linkage map (data not shown). It may mean that the epistatic effects of the MC4R alleles suggested in Line E have made it difficult to observe the MC4R
locus in most QTL experiments which have involved crosses between Chinese and European/American lines. It is likely that the effect of some alleles will be variable in the different backgrounds and hard to detect in QTL experiments involving genetically divergent breeds.
The effect of MC4R variant will possibly be explained by further studies on the biological effect caused by this mutation in other pig breeds and lines.
However, given the -strong relationship of MC4R variants to leanness, growth and feed intake, this mutation could be used immediately for merker assisted selection (Meuwissen and Goddard 1996) to develop lines of pigs to satisfy particular customer requirements. For instance, in sow lines where appetite is normally decreased after farrowing, selection for the MC4R 2 allele could help improve feed intake. Furthermore, in some lines deemed to be too fat, selection for allele 1 could be employed and in lines that were considered too slow growth allele 2 selection could be also employed. Therefore, genotyping for the MC4R mutation in pig breeding lines will improve the selection efficiency of feed related production traits including growth and leanness. The candidate gene approach has also been used for investigating the role of the porcine leptin gene (Jiang and Gibson 1999).
However, in the leptin case, although there was evidence for an association between a leptin polymorphism and backfat depth in a cross between a commercial breed and an unimproved line, there was no clear association in the different commercial lines tested (Jiang and Gibson 1999).
Therefore, it should not be assumed that since one fmds a gene that one can assume a relationship exists. In contrast, with MC4R we have determined that variation in this candidate gene can explain significant variation for backfat, growth rate, and feed intake in commercial lines of pigs. These results with MC4R illustrate the potential value of comparative genetic analyses using candidate genes in livestock genomics.
Number of observations (males/females/totals) for Days to 110 kg and backfat MC4 LINE A LINE B LINE C LINE D Total Line E
R
Days to 110kg MC4 LINE A LINE B LINE C LINE D Total Line E
R
11 166.3+/-0.8 168.4+/-1.4 170.0+/-2.4 167.9+/-0.9 219.1+/-4.8 12 165.6+/-0.9 166. 8+/-1.1 163.9+/-1.0 170.2+/-1.8 166.9+/-0.8 212. 2+/-3 .4 22 162. 3+/-2.3 166. 8+/-1. 5 161. 5+/-0. 8 167. 0+/-1.9 164.6+/-0.9 211.4+/-4.0 P <.24 P <.47 P <.007 P <.10 P <.001 P <.27 10t' rib Backfat (mm) MC4 LINE A LINE B LINE C LINE D Total Line E
R
11 10.7+/-0.2 12.1+/-0.2 9.8+/-0.5 11.1+/-0.2 22.8+/-1.2 12 11.2+/-0.2 12. 5+/-0.2 12.3+/-0.2 10.5+/-0.4 11.6+/-0.2 21.5+/-0.9 22 12. 5+/-0. 5 12. 6+/-0.3 12.7+/-0.2 10.9+/-0.4 12.0+/-0.2 20.3+/-1.0 P <.02 P <.31 P <.06 P <.05 P<.001 P <.17 Number of observations (males/females/totals for Test dailyg~
MC4 1 LINE A LINE B LINE C LINE D Total Line E
R
Test daily gain ( dav) MC4 LINE A LINE B LINE C LINE D Total Line E
R
11 892.6+/-10.4 841.7+/-13.8 882.2+/-18.4 871.9+/-10.2 688.8+/-24.5 12 913.3+/-11.6 868.4+/-12.1 882.2+/-12.9 883.7+/-14.3 885.1+/-8.9 676.2+/-17.6 22 982.8+/-22.8 862.4+/-15.1 913.4+/-10.5 904.6+/-15.1 908.8+/-9.3 692.5+/-20.4 P <.001 P <.28 P <.006 P <.20 P <.001 P <.66 Number of observations (males/females/total) for average daily feed intake MC4R LINE A LINE B LINE C LINE D Total Line E
Average daily feed intake (kg/day). boars only excent LINE E which was gilts onlv MC4 LINE A LINE B LINE C LINE D Total Line E
R
11 2.31+/-0.2 1.78+/-0.09 1.75+/-0.06 1.94+/-0.07 2.05+/-0.10 12 2.11+/-0.3 1.90+/-0.07 1.97+/-0.10 1.90+/-0.07 2.03+/-0.06 2.03+/-0.07 22 2.15+/-0.4 1.97+/-0.06 2.00+/-0.07 1.97+/-0.08 2.11+/-0.06 2.08+/-0.08 P <.84 P <.14 P <.56 P <.14 P <.01 P <.36 Having described the invention with reference to particular compositions, theories of effectiveness, and the like, it will be apparent to those of skill in the art that it is not intended that the invention be limited by such illustrative embodiments or mechanisms, and that modifications can be made without departing from the scope or spirit of the invention, as defined by the appended claims. It is intended that all such obvious modifications and variations be included within the scope of the present invention as =-defined in the appended claims. The claims are meant to cover the claimed components and steps in any sequence which is effective to meet the objectives there intended, unless the context specifically indicates to the contrary.
Andersson LB (1996) "Genes and obesity", Ann Med., 28:5-7.
Arden KC (1990). "The Receptors for Prolactin and Growth Hormone are Localized in the same Region of Human Chromosome 5", Cylogenet. Cell Genet. 53:161-165.
Barinaga M (1996). "Researchers Nail Down Leptin Receptor", Srien 271:913.
Bray GA (1978). Pyysio . Rev. 59, 719-809.
Casas-Carillo E (1997) "Mapping genomic regions associated with growth rate in pigs", I
AnimSci 75:2047-2053.
Chajlani V, "Molecular Cloning of a Novel Human Melanocortin Receptor", Riochem.
Biophvs. Res. Commun., 195, 866-873.
Chen H (1995). "Evidence that the diabetes gene encodes the leptin receptor:
Identification of a mutation in the leptin receptor gene in db/db mice", cAU 84, 491-495.
Chevalet C (1996). CABIOS. In Press.
Chua SC (1996). $sjepc 271,994-996.
Chung WK (1996). Genome Res. 6, 431-438.
Cioffi JA (1996). Nature Med. 2, 585-589.
Cybulsky MI (1991). "Gene Structure, Chromosomal Location, and Basis for Altera.ative mRNA Splicing of the Human VCAM1 Gene". Proc. Nat. Acad. Sci. 88:7859-7863.
Dekkers JCM (1998) "Optimizing selection for quantitative traits with information on an identified locus in outbred population", Genet R 71:257-275.
Flier JS (1998), "Obesity and the hypothalamus: Novel peptides for new pathways", ~
92:437-440.
Frandberg P (1997) "Glutamine2's and arginen in human melanocortin 5 receptor determines its low affinity to MSH",13iochem Biophys Res ConLmLn 236:489-492.
Frankel WN (1996) "Who's afraid of epistasis?" Nat Ggng~ 14:371-373.
Gantz I(1993a) "Molecular Cloning of a Novel Melanocortin Receptor",1. Biol.
Chem. -268, 8246-8250.
Gantz (1993) "Molecular Cloning, Expression in Gene Localization of a Fourth Melanocortin Receptor", J. Biol. Chem. 268, 15174-15179.
Gantz (1994) "Molecular Cloning Expression and Characterization of a Fifth Melanocortin Receptor", Biochem. Biophys. Res. Comm., 200, 1214-1220.
Giridharan NV (1998) "Animal models of obesity and their usefulness in molecular approach to obesity", Indian J Med res 108:225-242.
Gotoda T (1997) "Molecular screening of the human melanocortin-4 receptor gene:
identification of a missense variant showing no association with obesity, plasma glucose, or insulin" Diabetologia 40:976-979.
Goureau A (1996). Sienomics. In Press.
Griffon N (1994) "Molecular Cloning and Characterization of the Rat Fifth Melanocortin Receptor", Biochem. Biophys. Res. Comm., 200, 1007-1014.
Helm J (1994) "Rapid Communication: SacI Restriction Fragment Length Polymorphism with a Porcine Vascular Cell Adhesion Molecule 1(VCAM1) cDNA Fragment", L
Anim. Science 72:2764.
Hinney A (1999) "Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans" J Clin Endocrinol Metab 84:1483-1486.
Huszar (1997) "Targeted disruption of the Melanocortin-4 Receptor Results in /Obesity in Mice", Ct1188:131-141.
Kask A (1998) "Evidence that orexigenic effects of melanocortin 4 receptor antagonist HS014 are mediated by neuropeptide Y" Biochem Biophys Res Commu~n 248:245-249.
Kim KS (1999) "Rapid Communication: Linkage and physical mapping of the porcine Melanocortin-4 Receptor (MC4R gene" J Anim Sci (submitted).
Knorr C (1997) "Associations of GH gene variants with performance traits in F2 generations of European wild boar, Pietrain and Meishan pigs" Anim Genet 28:124-128.
Knott SA (1998) "Multiple*marker mapping of quantitative trait loci in a cross between outbred wild boar and large white pigs" Genetics 149:1069-1680. -Labbe O(1994) "Molecular Cloning of a Mouse Melanocortin-5 Receptor Gene Widely Expressed in Peripheral Tissues", Biochemistrv, 33, 4543-4549.
Lee GH (1996). ature 379, 632-635.
Lu Dongsi "Agouti Protein is an Antagonist of the Melanocyte-Stimulating Hormone Receptor" Letters to Nature.
Marsh DJ (1999) "Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides" Nat Genet 21:119-122.
Messer L, (1996a) "Mapping and Investigation of Candidate Genes for Litter Size in French Large White Pigs" ISAG Proceedi= (submitted).
Messer L(1996b) "Linkage Mapping of the Retinoic Acid Receptor Gamma (RARG) Gene to Porcine Chromosome 5". Anim. Genet. (in press).
Messer L (1996c) "Linkage mapping of the Retinol Binding Protein 4 (RBP4) Gene to Porcine Chromosome 14". Mammal. Genome (in press).
Meuwissen THE (1996) "The use of marker haplotypes in animal breeding schemes"
Genet Sel Evol 28:161-176.
Montjoy KG (1992) "The Cloning of a Family of Genes that Encode the Melanocortin Receptors", i n 257, 1248-1251.
Montjoy KG (1994) "Localization of the Melanocortin-4 Receptor (MC4-R) In Neuroendocrine In Autonomic Control Circuits in the Brain" Mol. Endocrinol. 8, 1298-1308.
Paszek A (1996) "Genomic Scan for Quantitative Trait Loci in Swine." Proceed.
Midwest.
ASAS Meeting, p. 24.
Paszek AA (1999) "Interval mapping of growth in divergent swine cross" Mamm Genome 10:117-122.
Phillips M (1996) "Leptin Receptor Missense Mutation in the Fatty Zucker Rat", Nature Genetics 13:18-19.
Pomp D (1997) "Genetic dissection of obesity in polygenic animal models" Behav Genet 27:285-306.
Robbins LS (1993) "Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function" f&H 72:827-834.
Robic A (1996). Mamm. Genome 7, 438-445.
Rohrer GA (1998) "Identification of quantitative trait loci affecting carcass composition in swine: I. Fat deposition traits" J Anim Sci 76:2247-2254.
Rothschild MF (1996). "The Estrogen Receptor Locus is Associated With a Major Gene for Litter Size in Pigs". PNAS 93: 201-205.
Rothschild MF(1999) "Advances in pig genomics and industry applications"
AgBiotechNet 1:1-8.
1 o Schwartz MW (1999) "Model for the regulation of energy balance and adiposity by the central nervous system" Am J Clin Nutr 69:584-96.
Seeley RJ (1997) "Melanocortin receptors in leptin effects", Nature 390:349.
Tartaglia LA (1995) "Identification and Expression Cloning of a Leptin Receptor" CgE
83:1263-1271.
Tatro JB (1996) "Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides", Neuroimmunomodulation 3:259-284.
Truett GE (1995). Mamm. Genome 6, 25-30.
Vaisse C (1998) "A frameshift mutation in human MC4R is associated with a dominant form of obesity" Nat Genet 20:113-114.
Valverde P (1995) "Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans" NatGenet 11:328-330.
Wang L (1998) "A direct search for quantitative trait loci on chromosomes 4 and 7 in pigs"
J Anim Sci 76:2560-2567.
Warner CM (1991). "The Swine Major Histocompatibility Complex (SLA)" in Immunogenetics of the MHC, VCH Publishers, NY, NY, pp. 368-397.
Winick JD (1996). Genomics 36, 221-222.
Xy Y (1994) "Identification of the Ped Gene at the Molecular Level: The Q9 MHC
Class I
Transgene Converts the Ped Slow Phenotype to Ped Fast Phenotype" Biol. Reprod.
51:695-699.
Yeo GS (1998) "A frameshift mutation in MC4R associated with dominantly inherited human obesity" I~a ne 20:111-112.
Yerle M (1996). QjQgenet. Cell Genet. 73, 194-202.
Youngs CR (1993) "Investigation into the Control of Litter Size- in Swine: I.
Comparative --Studies on in vitro Development of Meishan and Yorkshire Preimplantation Embryos" J. Anim. Sci., 1561-1565.
Yu TP (1995) "Association of PIT1 polymorphisms with growth and carcass traits in pigs"
J Anim Sci 73:1282-1288.
Zhang Y (1994) "Positional cloning of the mouse obese gene and its human homologue", Nat 372:425-432.
Ziang ZH (1999) "Genetic polymorphisms in the leptin gene and their association with fatness in four pig breeds" Mamm Genome 12:191-193.
. ~ ' SEQUENCE LISTING
<110> Iowa State University Research Foundation <120> Melanocortin-4 Receptor Gene and Use as a Genetic Marker for Fat Content, Weight Gain, and/or Feed Consumption in Animals <130> 2926/0004 <140> 2,337,495 <141> 1999-07-26 <150> PCT/US99/16862 <151> 1999-07-26 <150> 60/094,287 <151> 1998-07-27 <150> 60/116,196 <151> 1999-01-15 <160> 11 <170> PatentIn Ver. 2.0 <210> 1 <211> 746 <212> DNA
<213> porcine <220>
<221> variation <222> (678) <223> G/A
<400> 1 acaagaatct gcattcaccc atgtactttt tcatctgtag cctggctgtg gctgatatgc 60 tggtgagcgt ttccaatggg tcagaaacca ttgtcatcac cctattaaac agcacggaca 120 cggacgcaca gagtttcaca gtgaatattg ataatgtcat tgactcagtg atctgtagct 180 ccttactcgc ctcaatttgc agcctgcttt cgattgcagt ggacaggtat tttactatct 240 tttatgctct ccagtaccat aacattatga cagttaagcg ggttggaatc atcatcagtt 300 gtatctgggc agtctgcacg gtgtcgggtg ttttgttcat catttactca gatagcagtg 360 ctgttattat ctgcctcata accgtgttct tcaccatgct ggctctcatg gcttctctct 420 atgtccacat gttcctcatg gccagactcc acattaagag gatcgccgtc ctcccaggca 480 ctggcaccat ccgccaaggt gccaacatga agggggcaat taccctgacc atcttgattg 540 gggtctttgt ggtctgctgg gcccccttct tcctccactt aatattctat atctcctgcc 600 cccagaatcc atactgtgtg tgcttcatgt ctcactttaa tttgtatctc atcctgatca 660 tgtgtaattc catcatcgat cccctgattt atgcactccg gagccaagaa ctgaggaaaa 720 ccttcaaaga gatcatctgt tgctat 746 <210> 2 <211> 840 <212> DNA
<213> Homo sapiens <400> 2 atatcttagt gattgtggca atagccaaga acaagaatct gcattcaccc atgtactttt 60 tcatctgcag cttggctgtg gctgatatgc tggtgagcgt ttcaaatgga tcagaaacca 120 ttatcatcac cctattaaac agtacagata cggatgcaca gagtttcaca gtgaatattg 180 ataatgtcat tgactcggtg atctgtagct ccttgcttgc atccatttgc agcctgcttt 240 caattgcagt ggacaggtac tttactatct tctatgctct ccagtaccat aacattatga 300 cagttaagcg ggttgggatc agcataagtt gtatctgggc agcttgcacg gtttcaggca 360 ttttgttcat catttactca gatagtagtg ctgtcatcat ctgcctcatc accatgttct 420 tcaccatgct ggctctcatg gcttctctct atgtccacat gttcctgatg gccaggcttc 480 acattaagag gattgctgtc ctccccggca ctggtgccat ccgccaaggt gccaatatga 540 agggagcgat taccttgacc atcctgattg gcgtctttgt tgtctgctgg gccccattct 600 tcctccactt aatattctac atctcttgtc ctcagaatcc atattgtgtg tgcttcatgt 660 ctcactttaa cttgtatctc atactgatca tgtgtaattc aatcatcgat cctctgattt 720 atgcactccg gagtcaagaa ctgaggaaaa ccttcaaaga gatcatctgt tgctatcccc 780 tgggaggcct ttgtgacttg tctagcagat attaaatggg gacagagcac gcaatatagg 840 <210> 3 <211> 746 <212> DNA
<213> porcine <400> 3 acaagaatct gcattcaccc atgtactttt tcatctgtag cctggctgtg gctgatatgc 60 tggtgagcgt ttccaatggg tcagaaacca ttgtcatcac cctattaaac agcacggaca 120 cggacgcaca gagtttcaca gtgaatattg ataatgtcat tgactcagtg atctgtagct 180 ccttactcgc ctcaatttgc agcctgcttt cgattgcagt ggacaggtat tttactatct 240 tttatgctct ccagtaccat aacattatga cagttaagcg ggttggaatc atcatcagtt 300 gtatctgggc agtctgcacg gtgtcgggtg ttttgttcat catttactca gatagcagtg 360 ctgttattat ctgcctcata accgtgttct tcaccatgct ggctctcatg gcttctctct 420 atgtccacat gttcctcatg gccagactcc acattaagag gatcgccgtc ctcccaggca 480 ctggcaccat ccgccaaggt gccaacatga agggggcaat taccctgacc atcttgattg 540 gggtctttgt ggtctgctgg gcccccttct tcctccactt aatat+tctat atctcctgcc 600 cccagaatcc atactgtgtg tgcttcatgt ctcactttaa tttgtatctc atcctgatca 660 tgtgtaattc catcatcaat cccctgattt atgcactccg gagccaagaa ctgaggaaaa 720 ccttcaaaga gatcatctgt tgctat 746 <210> 4 <211> 311 <212> PRT
<213> Homo sapiens <220>
<221> miscfeature <222> () . . () <223> "X" can be any amino acid <400> 4 Gin Leu Phe Val Ser Pro Glu Val Phe Val Thr Leu G:Ly Val Ile Ser Leu Leu Glu Asn Ile Leu Val Ile Val Ala Ile Ala Lys Asn Lys Asn Leu His Ser Pro Met Tyr Phe Phe Ile Cys Ser Leu A1.a Val Ala Asp Met Leu Val Ser Val Ser Asn Gly Ser Glu Thr Ile Ile Ile Thr Leu Leu Asn Ser Thr Asp Thr Asp Ala Gin Ser Phe Thr Val Asn Ile Asp Asn Val Ile Asp Ser Val Ile Cys Ser Ser Leu Leu A=La Ser Ile Cys Ser Leu Leu Ser Ile Ala Val Asp Arg Tyr Phe Thr I}.e Phe Tyr Ala Leu Gln Tyr His Asn Ile Met Thr Val Lys Arg Val G:1y Ile Ser Ile 115 120 1:25 Ser Cys Ile Trp Ala Ala Cys Thr Val Ser Gly Ile Leu Phe Ile Ile Tyr Ser Asp Ser Ser Ala Val Ile Ile Cys Leu Ile Thr Met Phe Phe Thr Met Leu Ala Leu Met Ala Ser Leu Tyr Val His Met Phe Leu Met Ala Arg Leu His Ile Lys Arg Ile Ala Val Leu Pro G.1y Thr Gly Ala Ile Arg Gln Gly Ala Asn Met Lys Gly Ala Ile Thr Leu Thr Ile Leu Ile Gly Val Phe Val Val Cys Trp Ala Pro Phe Phe Leu His Leu Ile Phe Tyr Ile Ser Cys Pro Gin Asn Pro Tyr Cys Val Cys Phe Met Ser His Phe Asn Leu Tyr Leu Ile Leu Ile Met Cys Asn Ser Ile Ile Asp Pro Leu Ile Tyr Ala Leu Arg Ser Gln Glu Leu Arg Lys Thr Phe Lys Glu Ile Ile Cys Cys Tyr Pro Leu Gly Gly Leu Cys Asp Leu Ser Ser Arg Tyr Ala Pro Pro Glu Asn Asp Ile Xaa Val Ile Cys Asn Phe Ile Asp Glu Asn Thr Ile Ala Leu <210> 5 <211> 248 <212> PRT
<213> porcine <400> 5 Lys Asn Leu His Ser Pro Met Tyr Phe Phe Ile Cys Ser Leu Ala Val Ala Asp Met Leu Val Ser Val Ser Asn Gly Ser Glu Thr Ile Val Ile Thr Leu Leu Asn Ser Thr Asp Thr Asp Ala Gln Ser Phe Thr Val Asn 35 40 4; 5 Ile Asp Asn Val Ile Asp Ser Val Ile Cys Ser Ser Leu Leu Ala Ser Ile Cys Ser Leu Leu Ser Ile Ala Val Asp Arg Tyr Phe Thr Ile Phe . ~ , Tyr Ala Leu Gln Tyr His Asn Ile Met Thr Val Lys A:rg Val Gly Ile Ile Ile Ser Cys Ile Trp Ala Val Cys Thr Val Ser G:ly Val Leu Phe Ile Ile Tyr Ser Asp Ser Ser Ala Val Ile Ile Cys Leu Ile Thr Val Phe Phe Thr Met Leu Ala Leu Met Ala Ser Leu Tyr Val His Met Phe Leu Met Ala Arg Leu His Ile Lys Arg Ile Ala Val Leu Pro Gly Thr Gly Thr Ile Arg Gln Gly Ala Asn Met Lys Gly Ala I:1e Thr Leu Thr Ile Leu Ile Gly Val Phe Val Val Cys Trp Ala Pro Phe Phe Leu His Leu Ile Phe Tyr Ile Ser Cys Pro Gln Asn Pro Tyr Cys Val Cys Phe Met Ser His Phe Asn Leu Tyr Leu Ile Leu Ile Met Cys Asn Ser Ile Ile Asn Pro Leu Ile Tyr Ala Leu Arg Ser Gln Glu Leu Arg Lys Thr Phe Lys Glu Ile Ile Cys Cys Tyr <210> 6 <211> 20 <212> DNA
<213> porcine <400> 6 tggcaatagc caagaacaag 20 <210> 7 <211> 20 <212> DNA
<213> porcine <400> 7 caggggatag caacagatga 20 <210> 8 <211> 18 <212> DNA
<213> porcine <400> 8 ttaagtggag gaagaagg 18 <210> 9 <211> 19 <212> DNA
<213> porcine <400> 9 cattatgaca gttaagcgg 19 <210> 10 <211> 20 <212> DNA
<213> porcine <400> 10 taccctgacc atcttgattg 20 <210> 11 <211> 22 <212> DNA
<213> porcine <400> 11 atagcaacag atgatctctt tg 22
Claims (20)
OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A method of identifying a pig which possesses a genotype indicative of the metabolic traits of fat content, growth rate, and/or feed consumption, the method comprising:
a) obtaining a nucleic acid sample from the pig, said sample comprising a MC4R gene;
b) identifying a polymorphism in the MC4R gene at a position that corresponds to position 678 of SEQ ID NO:1; and c) relating the polymorphism to a metabolic trait of fat content, growth rate, and feed consumption, wherein a guanine at position 678 of SEQ ID NO:1 is indicative of a pig more likely to have less back fat, lower daily gain, and/or lower feed intake than a pig with an adenine at position 678 of SEQ ID NO: 1.
a) obtaining a nucleic acid sample from the pig, said sample comprising a MC4R gene;
b) identifying a polymorphism in the MC4R gene at a position that corresponds to position 678 of SEQ ID NO:1; and c) relating the polymorphism to a metabolic trait of fat content, growth rate, and feed consumption, wherein a guanine at position 678 of SEQ ID NO:1 is indicative of a pig more likely to have less back fat, lower daily gain, and/or lower feed intake than a pig with an adenine at position 678 of SEQ ID NO: 1.
2. The method of claim 1 wherein the step of identifying the polymorphism is a method employing allele specific oligonucleotides.
3. The method of claim 1 wherein the step of identifying the polymorphism is selected from the group consisting of restriction fragment length polymorphism (RFLP) analysis, heteroduplex analysis, single strand conformational polymorphism (SSCP) analysis, denaturing gradient gel electrophoresis (DGGE),temperature gradient gel electrophoresis (TGGE), and use of linked genetic markers.
4. The method of claim 3 wherein the step of identifying the polymorphism comprises RFLP analysis.
5. The method of claim 1 further comprising the step of amplifying the MC4R
gene sequence.
gene sequence.
6. The method of claim 5 further comprising the step of digesting the amplified region with the restriction endonuclease Taq I.
7. The method of claim 5 wherein the amplifying primers used are selected from the group consisting of SEQ. ID NO:6, SEQ. ID NO:7, SEQ. ID NO:8, SEQ. ID
NO:9, SEQ.
ID NO:10, and SEQ. ID NO:11.
NO:9, SEQ.
ID NO:10, and SEQ. ID NO:11.
8. The method of claim 2 wherein the oligonucleotides comprise a plurality of oligonucleotides having the nucleotide sequence represented by SEQ ID NO:6.
9. The method of claim 2 wherein the oligonucleotides comprise a plurality of oligonucleotides having the nucleotide sequence represented by SEQ ID NO:7.
10. The method of claim 2 wherein the oligonucleotides comprise a plurality of oligonucleotides having the nucleotide sequence represented by SEQ ID NO:8.
11. The method of claim 2 wherein the oligonucleotides comprise a plurality of oligonucleotides having the nucleotide sequence represented by SEQ ID NO:9.
12. The oligonucleotide of claim 2 wherein the oligonucleotide has the nucleotide sequence represented by SEQ ID NO:10.
13. The oligonucleotide of claim 2 wherein the oligonucleotide has the nucleotide sequence represented by SEQ ID NO:11.
14. A method of identifying a pig which possess a genotype indicative of the metabolic traits of fat content, growth rate, and/or feed consumption, the method comprising:
obtaining a sample of genomic DNA, said sample comprising a MC4R gene;
assaying the sample for the presence of a genotype in the MC4R gene at a position that corresponds to position 678 of SEQ ID NO:1, wherein the genotype of a guanine at position 678 of SEQ ID NO:1 is identifiable by digesting the sample with Taq I
restriction enzyme to obtain fragments, separating the fragments obtained from the digestion, and associating the guanine at position 678 of SEQ ID NO:1 with one or more metabolic traits selected from the group consisting of fat content, growth rate, and/or feed consumption, thereby identifying a pig which possess a genotype indicative of the metabolic traits of fat content, growth rate, and feed consumption.
obtaining a sample of genomic DNA, said sample comprising a MC4R gene;
assaying the sample for the presence of a genotype in the MC4R gene at a position that corresponds to position 678 of SEQ ID NO:1, wherein the genotype of a guanine at position 678 of SEQ ID NO:1 is identifiable by digesting the sample with Taq I
restriction enzyme to obtain fragments, separating the fragments obtained from the digestion, and associating the guanine at position 678 of SEQ ID NO:1 with one or more metabolic traits selected from the group consisting of fat content, growth rate, and/or feed consumption, thereby identifying a pig which possess a genotype indicative of the metabolic traits of fat content, growth rate, and feed consumption.
15. The method of claim 14 further comprising the step of selecting pigs for breeding which are predicted to have a trait of fat content, growth rate, and/or feed consumption by presence of said genotype.
16. The method of claim 14 wherein the site is identifiable by fragments of 466, 225, and 76 bp when a guanine is present at base 678 and fragments of 542 and 225 bp when an adenine is present when a restriction enzyme which cuts at the same recognition site as Taq I is used.
17. The method of claim 14 wherein the step of identifying comprises detecting the Taq I site by amplification.
18. A method for selecting pigs for the desired traits of lower fat content, faster growth rate, or lower feed consumption comprising the steps of a) obtaining a nucleic acid sample from a pig, said sample comprising a MC4R
gene;
b) identifying a polymorphism in the MC4R gene characterized by a nucleotide that corresponds to position 678 of SEQ ID NO:1, and c) selecting the pigs which have the nucleotide associated with lower fat content, faster growth rate, or lower feed consumption in position 678 of SEQ
ID NO:1, wherein a guanine at position 678 of SEQ ID NO:1 is indicative of a pig more likely to have less back fat, lower daily gain, and/or lower feed intake than a pig with an adenine at position 678 of SEQ ID NO: 1.
gene;
b) identifying a polymorphism in the MC4R gene characterized by a nucleotide that corresponds to position 678 of SEQ ID NO:1, and c) selecting the pigs which have the nucleotide associated with lower fat content, faster growth rate, or lower feed consumption in position 678 of SEQ
ID NO:1, wherein a guanine at position 678 of SEQ ID NO:1 is indicative of a pig more likely to have less back fat, lower daily gain, and/or lower feed intake than a pig with an adenine at position 678 of SEQ ID NO: 1.
19. A method of identifying pigs which possess a desired genotype indicative of the metabolic traits of fat content, growth rate, and/or feed consumption, the method comprising a) determining an association between a MC4R genotype and a trait of interest by obtaining a sample of pigs from a line or breed of interest, b) preparing genomic DNA from each pig in the sample, said sample comprising a MC4R gene;
c) determining the genotype of the MC4R gene at a position that corresponds to position 678 of SEQ ID NO:1, d) calculating the association between the MC4R genotype at position 678 of SEQ ID NO:1 and the trait of fat content, growth rate, and/or feed consumption in said pig, wherein a guanine at position 678 of SEQ ID NO:1 is indicative of a pig more likely to have less back fat, lower daily gain, and/or lower feed intake than a pig with an adenine at position 678 of SEQ ID
NO:1.
c) determining the genotype of the MC4R gene at a position that corresponds to position 678 of SEQ ID NO:1, d) calculating the association between the MC4R genotype at position 678 of SEQ ID NO:1 and the trait of fat content, growth rate, and/or feed consumption in said pig, wherein a guanine at position 678 of SEQ ID NO:1 is indicative of a pig more likely to have less back fat, lower daily gain, and/or lower feed intake than a pig with an adenine at position 678 of SEQ ID
NO:1.
20. A method for identifying a marker correlated with the metabolic traits of fat content, growth rate, and feed consumption comprising the steps of obtaining a sample of genetic material from a pig, said sample comprising a MC4R gene;
assaying said MC4R gene presented in said sample for a polymorphism at a position that corresponds to position 678 of SEQ ID NO: 1;
correlating whether a statistically significant association exists between said polymorphism and the metabolic traits of fat content, growth rate, and/or feed consumption in a pig of a particular breed, strain, population, or group whereby said pig can be characterized for said marker.
assaying said MC4R gene presented in said sample for a polymorphism at a position that corresponds to position 678 of SEQ ID NO: 1;
correlating whether a statistically significant association exists between said polymorphism and the metabolic traits of fat content, growth rate, and/or feed consumption in a pig of a particular breed, strain, population, or group whereby said pig can be characterized for said marker.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9428798P | 1998-07-27 | 1998-07-27 | |
US11618699P | 1999-01-15 | 1999-01-15 | |
US60/094,287 | 1999-01-15 | ||
US60/116,186 | 1999-01-15 | ||
PCT/US1999/016862 WO2000006777A2 (en) | 1998-07-27 | 1999-07-26 | Melanocortin-4 receptor gene and use as a genetic marker for fat content, weight gain, and/or feed consumption of animals |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2337495A1 CA2337495A1 (en) | 2000-02-10 |
CA2337495C true CA2337495C (en) | 2008-03-18 |
Family
ID=26788709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002337495A Expired - Lifetime CA2337495C (en) | 1998-07-27 | 1999-07-26 | Melanocortin-4 receptor gene and use as a genetic marker for fat content, weight gain, and/or feed consumption of animals |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1100970A2 (en) |
JP (1) | JP3790102B2 (en) |
CN (1) | CN1193102C (en) |
AU (1) | AU758179B2 (en) |
BR (1) | BR9912460A (en) |
CA (1) | CA2337495C (en) |
HU (1) | HUP0102715A3 (en) |
MX (1) | MXPA01001100A (en) |
PL (1) | PL346223A1 (en) |
WO (1) | WO2000006777A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002064091A2 (en) | 2001-02-13 | 2002-08-22 | Palatin Technologies, Inc. | Melanocortin metallopeptides for treatment of sexual dysfunction |
US6803190B1 (en) | 1998-07-27 | 2004-10-12 | Iowa State University Research Foundation, Inc. | Melanocortin-4 receptor gene and use as a genetic marker for fat content, weight gain, and/or feed consumption of animals |
BR0109655A (en) | 2000-03-30 | 2004-01-13 | Univ Iowa State Res Found Inc | Genetic markers for improved meat characteristics in animals |
WO2001079222A2 (en) * | 2000-04-12 | 2001-10-25 | Genaissance Pharmaceuticals, Inc. | Haplotypes of the mc4r gene |
US20030032791A1 (en) * | 2000-06-26 | 2003-02-13 | Alan Robertson Scott | Novel melanocortin-4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate |
KR100427645B1 (en) * | 2001-07-24 | 2004-04-28 | 한국생명공학연구원 | Human melanocortin-4 receptor specific antibody and the preparation method thereof |
CA2387003A1 (en) * | 2002-05-21 | 2003-11-21 | 984012 Alberta Ltd. | Method for improving efficiencies in livestock production |
AU2003303598A1 (en) | 2002-12-31 | 2004-07-29 | Mmi Genomics, Inc. | Compositions, methods, and systems for inferring bovine breed |
EP2286825B1 (en) * | 2005-07-08 | 2016-09-28 | Ipsen Pharma | Melanocortin receptor ligands |
CN100591692C (en) * | 2007-08-13 | 2010-02-24 | 中国农业科学院北京畜牧兽医研究所 | Pig fat deposition related protein and encoding genes and use thereof |
BRPI0819732B1 (en) | 2007-11-29 | 2019-05-07 | Monsanto Technology Llc | MEAT PRODUCT UNDERSTANDING ENDOGEN OIL, ARAQUIDONIC ACID (AA), ALPHA-LINOLENIC ACID (ALA), AND STETHARIDONIC ACID (SDA) |
CN103923997B (en) * | 2014-04-21 | 2016-09-07 | 广西壮族自治区水牛研究所 | The clone of buffalo milk production trait MC4R gene and the application as molecular labeling |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5940198A (en) * | 1995-12-22 | 1999-08-17 | U.S. Philips Corporation | Optical unit for synchronizing clock signals |
US5932779A (en) * | 1996-06-10 | 1999-08-03 | Millennium Pharmaceuticals, Inc. | Screening methods for compounds useful in the regulation of body weight |
-
1999
- 1999-07-26 MX MXPA01001100A patent/MXPA01001100A/en not_active Application Discontinuation
- 1999-07-26 JP JP2000562559A patent/JP3790102B2/en not_active Expired - Fee Related
- 1999-07-26 PL PL99346223A patent/PL346223A1/en not_active Application Discontinuation
- 1999-07-26 BR BR9912460-2A patent/BR9912460A/en not_active IP Right Cessation
- 1999-07-26 WO PCT/US1999/016862 patent/WO2000006777A2/en active IP Right Grant
- 1999-07-26 HU HU0102715A patent/HUP0102715A3/en unknown
- 1999-07-26 AU AU52301/99A patent/AU758179B2/en not_active Ceased
- 1999-07-26 CN CNB998111139A patent/CN1193102C/en not_active Expired - Fee Related
- 1999-07-26 CA CA002337495A patent/CA2337495C/en not_active Expired - Lifetime
- 1999-07-26 EP EP99937474A patent/EP1100970A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1100970A2 (en) | 2001-05-23 |
AU758179B2 (en) | 2003-03-20 |
PL346223A1 (en) | 2002-01-28 |
CN1328602A (en) | 2001-12-26 |
CA2337495A1 (en) | 2000-02-10 |
WO2000006777A2 (en) | 2000-02-10 |
AU5230199A (en) | 2000-02-21 |
CN1193102C (en) | 2005-03-16 |
WO2000006777A3 (en) | 2000-05-11 |
HUP0102715A2 (en) | 2002-09-28 |
JP2002521068A (en) | 2002-07-16 |
BR9912460A (en) | 2002-02-13 |
HUP0102715A3 (en) | 2004-10-28 |
MXPA01001100A (en) | 2002-08-20 |
JP3790102B2 (en) | 2006-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kim et al. | A missense variant of the porcine melanocortin-4 receptor (MC4R) gene is associated with fatness, growth, and feed intake traits | |
AU2001249589B2 (en) | Genetic markers for improved meat characteristics in animals | |
AU2001249589A1 (en) | Genetic markers for improved meat characteristics in animals | |
CA2337495C (en) | Melanocortin-4 receptor gene and use as a genetic marker for fat content, weight gain, and/or feed consumption of animals | |
US7244564B2 (en) | HMGA alleles and use of the same as genetic markers for growth, fatness, meat quality, and feed efficiency traits | |
US5935784A (en) | Prolactin receptor gene as a genetic marker for increased litter size in pigs | |
EP1846575A1 (en) | Dna markers for cattle growth | |
US6803190B1 (en) | Melanocortin-4 receptor gene and use as a genetic marker for fat content, weight gain, and/or feed consumption of animals | |
US20070037154A1 (en) | Fine mapping of chromosome 17 quantitative trait loci and use of same for marker assisted selection | |
US8003328B2 (en) | Bovine polymorphisms and methods of predicting bovine traits | |
US6458531B1 (en) | Leptin receptor gene as a genetic marker for leanness in pigs | |
US7074562B2 (en) | Ghrelin alleles and use of the same for genetically typing animals | |
EP1141390A1 (en) | Retinol binding protein 4 as a genetic marker for increased litter size | |
Liu et al. | Association of MC4R gene variants with carcass and meat quality traits in Qinchuan cattle | |
US20040259127A1 (en) | Approaches to identifying genetic traits in animals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20190726 |